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ABSTRACT
C-nitroso compounds are reactive intermediates in the toxic sequelae o f 
nitroarene metabolism. Alcohol dehydrogenase (ADH) contributes significantly to 
NADH-dependent C-nitroso reduction by cytosol relative to NAD(P)H: quinone 
oxidoreductase (NQOR). NADPH-dependent pNSP reduction by liver cytosol o f  ADfT 
animals is mostly dicumaro 1-sensitive which implicates NQOR as the major NADPH- 
dependent activity.
Although, extensive structural homology between horse and different isozymes 
o f human ADH exist, significant differences occur within the active site, which account 
for great variability among substrate specificities, kinetic constants, and response to 
inhibitors. We have studied the metabolic activity o f  horse liver alcohol dehydrogenase 
(HLADH), purified class I a a ,  P1P 1, and P2P2 , class II 7t, class III x and class IV a  
human isozymes, and human liver cytosol (HLC) towards the C-nitroso substrate pNSP. 
Significant differences in the reaction rates towards pNSP were observed between 
HLADH and the human isozymes. The relative order o f  the rates o f /?NSP reduction by 
ADH was HLADH > a a  > it > a  > x  > P2P2 > PiPi- />NSP reduction catalyzed by 
HLADH, purified class I a a ,  P1P 1, and P2P2 , class III x and class IV <7 human 
isozymes show pH dependence with maxima greater than or equal to pH 6. This pH 
dependence seemingly reflects a protein moiety involved in the proton relay system.
Thiodiglycol (TDG) can undergo oxidation catalyzed by ADH. We have 
compared the catalytic activity o f  purified human liver class I a a ,  P1P 1, P2 P2 and yiYi 
ADH, class II n  ADH, class III x  ADH, and class IV <7 ADH with respect to TDG 
oxidation. Specific activities with respect to TDG were 123, 79, 347, 647, and 12
xii
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nmol/min/mg for the a a ,  (J|(3i, P2P2, YiY«» and 7t ADH, respectively. Class III x ADH 
did not exhibit activity with this substrate. The specific activity o f  class IV a  ADH was 
estimated at about 1632 nmol/min/mg. The activities o f  class IV a  and class I Yi ADH 
are o f  significant interest because o f  their prevalence in the eyes, lungs, stomach and 
skin, all potential target organs o f sulfur mustard toxicity.
xiii
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CHAPTER 1 INTRODUCTION
Alcohol dehydrogenase (ADH; EC 1.1.1.1) is the primary enzyme responsible 
for the oxidation o f ethanol, with the production o f acetaldehyde and NADH being the 
first step of ethanol elimination in humans (1). The reaction follows an ordered bi bi 
mechanism in which the binding o f  cofactor, NAD+, near the enzyme active she 
precedes binding o f substrate. This catalytically inactive binary complex then binds one 
molecule o f ethanol to form the catalytically active ternary complex. Catalysis occurs 
instantly with hydride transfer from ethanol to the bound co factor. Acetaldehyde is then 
released, followed by the release o f  NADH. This reaction is reversible, with the ADH 
catalyzed reduction o f acetaldehyde resulting in the production o f  ethanol. Although its 
definitive functional activity is the oxidation o f ethanol, alcohol dehydrogenase is a key 
enzyme in phase I xenobiotic metabolism, having a variety o f  substrates.
Alcohol dehydrogenases constitute a complex system o f  proteins derived from 
gene duplications at minimally four different levels. The system includes proteins o f 
different type regarding family relationships and overall organization. It also includes 
different enzymes within each family, as well as different classes o f  the enzymes, and 
different isozymes within the classes, apart from allelic variants. The medium-chain 
alcohol dehydrogenases now constitute a well-established protein family with 
characterized relationships o f  general interest and include the classical alcohol 
dehydrogenases, the liver and yeast enzymes. In common, these enzymes typically 
contain a zinc ion at their active sites. The different enzymes within the family 
originated at an early stage o f evolution and exhibit characteristic properties, 
distinguishable in quaternary structure, substrate specificity, and internal 
deletions/insertions (2, 3).
1
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Mammalian zinc-containing ADH constitute an enzyme family o f multiple 
iso forms. Of these Horse Liver Alcohol Dehydrogenase (HLADH) is the most widely 
studied. Being an 80 kDa dimer, HLADH is composed o f two 40 kDa monomers, each 
containing 374 amino acids and two zinc ions, one having a structural function and the 
other a catalytic function.
1.1 Human ADH Isozymes
Humans produce more than 20 ADH isozymes composed o f as many as nine 
different subunits (4). The horse enzyme shares between 87% and 60% sequence 
homology with the human isozymes. Having been differentiated into five classes based 
on their electrophoretic mobilities and inhibition by pyrazole and some o f its 4- 
alkylated derivatives, the inter-class differences between the human isozymes are large 
and affect charge, enzyme activity, and inhibition patterns. The overall residue identity 
shows 60% homology between classes; many residues at the active site are substituted, 
especially in the substrate-binding pocket, which is large and hydrophobic in the 
traditional ethanol-active liver enzyme o f class I, but different in the enzymes o f  the 
other classes.
Genes at three loci, ADH 1, ADH 2, and ADH 3, code for the class I isozymes 
a-, p~, and y-ADHs, respectively, with allelic variants o f (3 and y (5, 6). These 
molecular forms are effectively inhibited by 4-methylpyrazole. Primary and secondary 
alcohols are almost equally good substrates for class 1 ADHs. Patterns o f class I 
isozymes also vary because o f allelic polymorphism within and among different racial 
groups. Variants involving the (3 subunit have been designated Pi (Caucasian), (32 
(Oriental), and pa (African) (6). Class II and class III each consist solely o f one
2
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isozyme, ti-ADH and x-ADH, respectively, which are relatively insensitive to pyrazole 
inhibition. Class II ADH, translated by ADH 4, acts on primary aliphatic alcohols and 
aromatic aldehydes (7). All human isozymes catalyze the oxidation o f ethanol; 
however, the Km o f  class II ADH for ethanol oxidation is significantly higher than that 
o f class I forms. O f the vertebrate ADHs that have been identified, only one form, class 
III ADH, has been conserved in all organisms (8). Class in has been implicated as the 
ancestral type, as supported by estimates o f  the divergence rate, and its presence in 
invertebrates and prokaroytes as well as animals (9). Class m  ADH functions in vitro 
as a glutathione-dependent formaldehyde dehydrogenase, which suggests that this was 
the original function that drove the evolution o f  ADH (10). Class III is a product o f the 
ADH 5 gene. The n  and x subunits share about 60% sequence homology with each 
other or the other isozymes and have not been observed to form heterodimers. Class IV 
is encoded by the ADH 7 locus, producing the o-ADH. Found predominately in the 
stomach, the o-ADH is considered to have a significant role in retinol metabolism and 
first-pass ethanol metabolism (11-13). As with HLADH, these medium chain 
dehydrogenases are dimeric 80kd NAD*- and zinc-dependent ADHs, containing 4 mol 
o f zinc per dimer (14, 15). These ADHs also illustrate separate genetic controls, with 
constituent forms (class III j ) ,  inducible forms (class I y), and genes differently 
expressed during ontogenesis, with fetal and adult forms (class I a , P, and y) (16, 17). 
Classes I through IV have been investigated extensively by analyses o f divergent 
natural variants and correlation o f their replacements with the residues lining the 
substrate-binding pocket (Table 1.1), where a minimum o f eleven positions are o f  major 
importance (18-20).
3
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Table 1.1 Residues lining the substrate-binding cleft of HLADH and Human ADHs.
Class Source Amino acid at position
(inner)______________  (middle)______________  (outer)
48 93 140 141 57 116 294 318 110 306 309
I Horse E Ser Phe Phe Leu Leu Leu Val lie Phe Met Leu
Human a Thr Ala Phe Leu Met Val Val lie Tyr Met Leu
Human (3 Thr Phe Phe Leu Leu Leu Val Val Tyr Met Leu
Human y Ser Phe Phe Val Leu Leu Val He Phe Met Leu
II Human it Thr Tyr Phe Phe Phe Leu Val Phe Leu Glu lie
III Human x Thr Tyr Tyr Met Asp Val Val Ala Leu Phe Val
IV Human a Thr Phe Phe Met Met He Val Val Leu Met Phe
Table has been adapted from Eklund et al., 1990 and Satre et al., 1994.(13, 19)
1.2 Mechanism of Catalysis: The Role of Zinc in ADH Catalysis
A great deal o f experimentation has been devoted to the role o f  the metal ion in 
catalysis, especially the mode o f  substrate binding and activation as well as the nature 
o f metal-linked equilibria, including the role o f  metal-bound water. Although much 
work has been done to evaluate the kinetic mechanism o f ADH catalyzed reactions, 
many questions remain concerning the coordination chemistry o f the catalytic zinc and 
its role in substrate binding and hydride transfer. It is not clear whether all substrates 
are bound directly to the active she zinc or whether a second-sphere o f  coordination 
occurs. Many investigators support a protein-substrate structure with the carbonyl 
oxygen o f an aldehyde substrate bound directly to the catalytic zinc in HLADH in a 
tetrahedral arrangement (21-24). On the other hand, some investigators have proposed 
that the metal ion remains coordinated to a water molecule and that the substrate is 
hydrogen bonded to this water molecule (25, 26). Necessary information to answer 
these questions is difficult to acquire because o f the uninformative zinc ion in the active
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
,E !J309
Fig. 1.1 Computer graphics model o f the active site o f (3 r  ADH. This model indicates 
the positions o f the active site residues, bound N A D \ and the structural zinc ion relative 
to the catalytic zinc ion. This model was generated using the Sybyl (Tripos Associates, 
Inc.) molecular modeling software, version 6.4. The coordinates o f the human Pi 
isozyme (PDB code 3HUD) are those o f Hurley et al. (27).
5
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site o f the enzyme. Because o f its chemical nature, zinc does not lend itself to 
conventional methods of studying the active site metal ligands.
13  Physiological Substrates 
1.3.1 Contribution to Phase 1 Metabolism
Aldehydes, ketones, and alcohols are Sequent functional groups that appear in 
drugs and other xenobiotics. These functional groups are often metabolized in vivo by 
oxidation or reduction. Since these functional groups often impart pharmacological 
properties, the oxidation or reduction o f  these groups is a means o f  detoxification (28). 
However, in some cases more reactive species may be produced and can lead to 
toxicity. One o f the most important enzymes for these reactions is ADH.
1.3.2 Activity in Ethanol Metabolism
Extrahepatic tissues contain isozymes o f  ADH with a much lower affinity for 
eth?nol than the hepatic isozymes; as a consequence, at the levels o f  ethanol achieved in 
the blood, these extrahepatic enzymes are inactive and, therefore, extrahepatic 
metabolism o f  ethanol is negligible, with the exception o f the stomach.
At least three different forms o f ADH exist in the stomach, with either high or 
low Km values for ethanol (11). Because o f  the extraordinarily high gastric ethanol 
concentration after alcohol ingestion, even the gastric ADH, with a  high Km for ethanoL, 
becomes active and significant gastric ethanol metabolism ensues. This “first pass 
alcohol metabolism” decreases the bioavailability o f  ethanol and represents a barrier 
against its systemic effects, at least when ethanol is consumed in small amounts.
Although other enzymes such as catalase and those of the Microsomal Ethanol 
Oxidizing System may have significant roles in ethanol oxidation, especially at chronic 
levels, the main pathway for ethanol disposition involves hepatic ADH, an enzyme o f
6
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the cell cytosol. Ethanol ingestion results in numerous enzymatic and metabolic changes 
in the liver and other organs and tissues (29). These changes include an increased 
NADH/NAD* ratio, a decrease in the hepatic ratio o f reduced versus oxidized 
glutathione, induction o f cytosolic glutathione-S-transferases, and conversion o f 
xanthine dehydrogenase to xanthine oxidase leading to an overall induction in the 
expression o f xanthine oxidase activity in the liver (30). As a net result o f  ethanol 
oxidation, an excess o f reducing equivalents in the liver, primarily as NADH, is 
obtained. The resulting enhanced NADH/NAD* ratio may produce a change in the ratio 
o f those metabolites that depend on NADH/NAD+ coupled reduction (31).
1.4 C-Nitroso Compounds as Substrates
1.4.1 Arylamines and Nitronrenes
Activation of nhroaromatic compounds to mutagens involves formation of 
partially reduced metabolites, such as C-nitroso- or hydroxylamino compounds (32).
The mutagenicity o f nitroarenes and arylamines is closely related to the steady-state 
concentrations o f the nitroso and hydroxylamino intermediates produced during their 
respective reductive and oxidative metabolism. Therefore, formation and removal o f 
the nitroso intermediates o f arylamines and nitroaromatics is an important consideration 
in the mutagenic expression o f  these compounds. The potent mutagenic and 
carcinogenic potential o f  nitro- and nitrosoarenes is widely accepted to involve their 
facile reduction to N-hydroxyarylamines (Scheme 1). The nitroso moiety may undergo 
a two electron reduction via a nitroxyl radical to hydroxylamine, which has been 
reported as the proximal carcinogen. The hydroxylamine may either undergo direct 
conversion to the primary carcinogen, the nitrenium ion, or it may be acetylated and by
7
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Scheme 1 Proposed 1 - and 2-electron reduction pathways o f nitroarenes. I. Nitroanion 
radical, II. Nitroso, HI. Nitroxyl radical, IV. Hydroxyl amine, V. Nitrenium ion, VI. 
Amine
way o f N,0-Transacetylase it is then converted to the DNA binding acetoxy 
hydroxylamine.
1.4.2 Nitroarene Reduction
Aromatic C-nitroso compounds are abundant in the environment (32). They are 
readily formed intermediates o f  reductive metabolism o f  nitroarenes and oxidative 
metabolism o f arylamines. Microsomal and cytosolic enzymes are involved in the 
metabolism o f mutagenic nitroarenes and arylamines (33-37). Arylamines are synthetic 
industrial compounds. Much research has been undertaken to understand the toxic 
sequelae o f arylamines. Nitroarenes are ubiquitous, anthropogenically generated
8
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contaminants formed predominantly by incomplete combustion (38). They have been 
detected in gasoline emissions, fly ash, cigarette smoke, grilled foods, incinerator 
emissions, residential home heaters and wood burning stoves (38, 39). Aromatic C- 
nitroso compounds have also been used in the vulcanization o f some synthetic rubbers, 
as antioxidants in lubricating oils.
In 1971, Dunn and Bernhard reported the reduction of/>-nitroso-N,N- 
dimethylaniline catalyzed by horse liver alcohol dehydrogenase. It was noted that the 
nitroso moiety is both isosteric and isoelectronic with aldehyde functionality. Purified 
horse liver ADH and yeast ADH catalyzed NADH-dependent reduction of/>nitroso- 
N.N-dimethylaniline to the corresponding amine (40-42). The cytosolic fraction o f  rat 
liver contains various NADH- or NADPH-linked enzymes which can reduce certain 
nitro so are nes to the corresponding amines (43). Based on the sensitivity o f  the reaction 
to pyrazole, a role for alcohol dehydrogenase in NADH-dependent C-nitroso reductase 
activity o f liver cytosol was indicated (44-48). ADH catalyzed the 4-electron reduction 
ofp-nitrosophenol to p-aminophenol and showed a slightly acidic pH optimum. The C- 
nitroso reductase activity o f porcine heart, which lacks ADH activity, co-eluted with 
menadione reductase activity upon partial purification and was supported by either 
NADH or NADPH (46,47). Maskos and Winston have shown that ADH catalyzes both 
the reduction o f  2-nitrosofluorene and the rearrangement o f  N-hydroxy-2- 
aminofluorene (36). Moreover, NADH-dependent C-nitroso reductase activity 
catalyzed by rat liver cytosol is inhibited more than 85% by pyrazole (48). Although 
ADH has been known to catalyze reduction o f  the C-nitroso functional group to its
9
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corresponding hydroxylamine for nearly two decades, the toxicological ramifications o f 
this reaction have not been fully explored.
1.5 Metabolism of 2 ^ ’-Thiobis-ethanol
Sulfur mustard is a poisonous chemical warfare agent. It was used as recently 
by Iraq to attack its own Kurdish population in the Iranian-occupied village o f Halbja in 
1988 (49). Mustard gas is toxic as droplets, liquid, vapor, and, primarily, in the form o f 
an aerosol. It is easily absorbed by many foodstuffs, porous materials, paint and varnish 
coatings, and rubber articles, all o f  which will remain contaminated for long intervals 
(50). Public concern has arisen from possible exposure and potential health hazards 
resulting from destruction o f  stockpiles o f these chemical agents. Scientific data are 
being accumulated concerning potential adverse effects, including toxicology, 
carcinogenicity, mutagenicity, and teratogenicity. Sulfur mustard is a poisonous 
chemical agent that exerts a local action on the eyes, skin, and respiratory tissues, with 
subsequent systemic action on the nervous, cardiac, and digestive systems in humans 
and laboratory animals (51).
Soon after introduction into body tissues, hydrolysis o f sulfur mustard occurs to 
form 2,2’-Thiobis-ethanol (thiodiglycol) and semimustard, which are relatively 
nontoxic. Recent research has shown that sulfur mustard inhibits serine and threonine 
phosphatases and that this inhibition was more closely related to the concentration of 
thiodiglycol (TDG) than the mustard itself (52). Subsequent observations have shown 
TDG to be a substrate for HLADH and ADH in human skin cytosol (53).
The objective o f  these studies was two fold: 1. To determine the role o f ADH 
in the reductive metabolism o f  C-nitroso compounds in cytosol where other nitroso 
reducing enzymes are present simultaneously; 2. To further elucidate the mechanism
10
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by which ADH catalyzes the reduction of C-nitroso substrates by comparing the 
activities o f HLC, purified HLADH, and purified human ADH isozymes with respect to 
the model C-nitroso substrate pNSP; and 3. To characterize the activities o f individual 
human ADH isozymes with respect to thiodiglycol. Evidence is presented to show 
distinctly different mechanisms and kinetics by these different systems.
11
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CHAPTER 2 P-NITROSOPHENOL REDUCTION BY LIVER CYTOSOL 
FROM ADH-POSITIVE AND NEGATIVE DEERMICE 
(PEROMYSCUS MANICULATUS)l
2.1 Introduction
Aromatic C-nitroso compounds are abundant in the environment (32). They are 
readily formed intermediates o f reductive metabolism o f  nitroarenes and oxidative 
metabolism o f  arylamines. The cytosolic fraction o f  rat liver contains various NADH- 
or NADPH-linked enzymes which can reduce certain nitrosoarenes to the corresponding 
amines (43). Based on the sensitivity o f the reaction to pyrazole, a role for alcohol 
dehydrogenase (ADH; EC 1.1.1.1) in NADH-dependent C-nitroso reductase activity o f 
liver cytosol was indicated (44-48). ADH catalyzed the 4-electron reduction o f p- 
nitrosophenol to p-aminophenol and showed a slightly acidic pH optimum. Purified 
horse liver ADH and yeast ADH catalyzed NADH-dependent reduction ofp-nitroso- 
N,N-dimethylaniline to the corresponding amine (40-42). NAD(P)H: quinone 
oxidoreductase (EC 1.6.99.2) has been shown to reduce a variety o f nitroso aromatics 
including /?-nitroso phenol, nitroso benzene, nitrosonaphthol and 5-nitroso-8-quinolinol 
(47). The C-nitroso reductase activity o f  porcine heart, which lacks ADH activity, co­
eluted with menadione reductase activity upon partial purification and was supported by 
either NADH or NADPH (46,47)
Activation of nitroaromatic compounds to mutagens occurs via nitroreduction 
and involves formation o f partially reduced metabolites such as C-nitroso or 
hydroxy lamino compounds. Therefore formation and removal of the nitroso 
intermediates o f arylamines and nitroaromatics is an important consideration in the 
mutagenic expression o f these compounds. The mutagenic and carcinogenic potential
1 Reprinted by Permission o f Archives o f  Biochemistry and Biophysics.
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of nitro and nitroso arenes is a function o f  their ability to be reduced to their 
corresponding N-hydroxylamine (54, 55). Although ADH has been known to catalyze 
reduction o f  the C-nitroso functional group to its corresponding hydroxy lamine for 
nearly two decades, the toxico logical significance o f  this reaction remains largely 
unexplored.
We have recently characterized NAD(P)H-dependent reduction o fp~ 
nitrosophenol by liver cytosol from male Sprague-Dawley rats that had been maintained 
for 30 days on either an alcohol-containing liquid diet or a control diet in which 
carbohydrate was substituted isocalorically for ethanol (48). Based on potent inhibition 
by dicumarol o f cytosolic NADPH-dependent p-nitrosophenol reduction, our studies 
indicated that this activity was mainly attributable to NAD(P)H: quinone 
oxidoreductase in liver; this was true with cytosol from ethanol- or pair-fed rats. The 
total p-nitro so phenol reductase o f cytosol from ethanol-fed rats was about 2 -fold higher 
than that o f controls and the apparent ethanol-inducible portion o f the activity was 
completely inhibitable by dicumaroL Pyrazole only weakly inhibited NADPH- 
dependent cytosolic reduction ofp-nitrosophenol by the ethanol- and pair-fed systems, 
respectively, which indicated a  relatively minor contribution of ADH. By contrast, 
NADH-dependent />-nitro so phenol reduction by cytosol from ethanol-and pair-fed rats 
was effectively inhibited by pyrazole (—60 %). Dicumarol was a relatively weak 
inhibitor o f NADH-dependent p-nitrosophenol reduction in both the ethanol and pair- 
fed systems. Thus, NADH-dependent C-nitroso reductase activity o f  rat liver appears to 
be predominantly ADH-catalyzed.
13
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The development o f an ADH-negative deermouse by Burnett and Felder (56) 
has contributed significantly to the understanding of the in vivo ramifications o f ADH 
(57). The model was used to show the predominant role o f  microsomal cytochrome 
P450 in non-ADH-dependent ethanol oxidation in vivo (58). As sundry other liver 
enzymes, eg. NAD(P)H: quinone oxidoreductase, xanthine oxidase (EC 1.1.3.22) or 
aldehyde oxidase (EC 1.2.3.1) are capable o f nitro, nitroso and hydroxylamino 
reduction in liver, the ADH-negative deermouse offers advantages in elucidating ADH 
and non-ADH metabolism o f nitroso and hydroxylamines in vitro and in vivo. Herein 
evidence is presented to show that ADH is the major NADH-dependent C-nitroso 
reductase o f  the deermouse liver and that in ADH-negative deermouse liver, NAD(P)H: 
quinone oxidoreductase is the predominant NADH- and NADPH- dependent C-nitroso 
reductase. The total insensitivity of/>-nitrosophenol reduction to allopurinol suggests 
the lack o f  a role for xanthine or aldehyde oxidase as a p-nitrosophenol reductase in 
liver cytosol o f both ADH-positive and negative deermice.
2.2 Materials and Methods
2.2.1 Chemicals and Enzymes
Allopurinol, dicumarol, pyrazole, NADH, NADPH, HLADH, and potassium 
ferricyanide were form Sigma (St. Louis, MO). />-Aminophenol, />-nitrosopheno 1, and 
phenol were from Aldrich Chemical Co. (Milwaukee, WI). All other chemicals were o f 
the highest grade commercially available.
2.2.2 Animals
ADH-positive (ADH*) and ADH-negative (ADH”) deermice were provided by 
Dr. Michael R. Felder, Department o f  Biology, University o f  South Carolina, Columbia,
14
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SC. These animals were acclimated for one week in the LSU animal housing facility on 
a 1 2 : 1 2  hour light:dark cycle and fed standard laboratory chow and water ad libitum.
2 .23  Preparation of Cytosolic Fractions
Cytosolic fractions (105,000 x g supernatants) were prepared by differential 
centrifugation o f  liver homogenates according to standard techniques in the literature 
(59). Fractions were aliquoted and stored at -80°C prior to use.
2.2.4 Enzyme Assays
Formation o f p-aminophenol from p-nitrosophenol was determined by a 
modification o f the procedure described by Horie et al. (44). Essentially, p- 
nitrosophenol (0.05- ImM) was incubated for 15 minutes in the presence o f 200 pM 
NADH or NADPH and an appropriate amount o f activating enzyme (approximately 
0.05 mg/ml cytosolic protein or 0.025 mg/ml purified HLADH) in 50 mM potassium 
phosphate buffer, pH 7.4, in a final volume o f  2 ml. The reaction was initiated by 
addition o f NAD(P)H and terminated by addition o f 300 pi o f 1 M Na2C 0 3. p - 
Aminophenol was detected spectrophotometrically by subsequent addition o f 300 pi of 
5% (w/v) aqueous phenol and 200 pi o f  0.2% (w/v) potassium ferricyanide. The color 
was allowed to develop for 15 min and the absorbance measured at 630 nm against a 
blank containing all reagents but the enzyme fraction. The concentration o f  p- 
aminophenol formed was calculated from a standard curve using commercially 
available p-aminophenoL Additional incubations contained 15 pM dicumarol, 5 mM 
pyrazole, or 20 pM allopurinol. At these inhibitor concentrations, the reduction o f 
dichlorophenolindolephenol (DCPIP) or p-nitro so phenol by purified NAD(P)H: 
quinone oxidoreductase, ethanol oxidation and p-nitrosophenol reduction by purified 
ADH and urate formation from hypo xanthine by purified xanthine oxidase were
15
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inhibited 80-90%. Higher concentrations were without further effect. Time course 
studies followed the basic procedure except that reactions were begun at individual time 
points so that all could be terminated simultaneously.
Anaerobic experiments were conducted as stated above except that the reactions 
were run in a nitrogen atmosphere. The reaction mixture and a solution o f  NADH were 
degassed with nitrogen for 15 min and sealed with a rubber septum. Reactions were 
initiated by injecting the degassed NADH directly through the septum o f test tubes 
containing the nitrogen saturated reaction mixture.
Cytosolic NAD(P)H: quinone oxidoreductase activity o f  deermouse liver cytosol 
was measured by monitoring the change in absorbance o f DCPIP essentially by the 
method o f Emster et al (60). Liver cytosolic ADH activities were measured by the 
method o f Bonnichsen et al (61), which is based on spectrophotometric measurement of
NADH formation from NAD+ in the presence o f ethanol.
The oxidation o f NAD(P)H catalyzed by either purified enzymes or cytosol was 
measured by following the loss o f absorbance o f the reduced pyridine nucleotide at 330 
nm. This wavelength was chosen instead o f the traditional 340 nm to correct for 
interferences at 340 nm by p-nitrosophenol (48). Specific activities were quantified
from the corrected millimolar extinction coefficient o f 5.87 m M '' • cm"' for the 
reduced pyridine nucleotide at 330 nm.
2.3 Results
2.3.1 NAD(P)H: Quinone Oxidoreductase and Alcohol Dehydrogenase Activities 
of Deermouse Liver Cytosol
The specific activities for dicumarol-sensitive, NADH- and NADPH-dependent 
DCPIP reduction (NAD(P)H: quinone oxidoreductase activity) catalyzed by liver
16
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
cytosol from ADH" deermice were essentially identical (25.4 ±3.1 and 25.1 ± 1.7 
nmol/min/mg cytosolic protein, respectively). With cytosol from ADH* deermice the 
specific activities were 7.2 ± 1 .2  and 11.1 ± 1.7 nmol/min/mg for NADH and NADPH, 
respectively. Thus NAD(P)H: quinone oxidoreductase activity is about 2-3 times 
greater in the ADH* deermouse than in the ADH*. The specific activity o f  liver 
cytosolic ADH in the ADH* and ADH* animals, respectively were 4.9 ± 0.7 and 0.4 ± 
0 . 2  nmol/min/mg protein.
2.3.2 p-Nitrosophenol Reduction by ADH* and ADH* Deermouse Cytosol
Cytosolic fractions from ADH* and ADH* deermice catalyze NAD(P)H- 
dependent reduction ofp-nitrosopheno 1 to p-aminophenol (Figs. 2.1A and 2 .1B). With 
either cofactor the reaction appears to be first order with respect to cytosolic protein 
concentration up to approximately 50 pg/ml. Figure 2.1 A also shows that NADH- 
dependent rates were about three times greater with ADH* cytosol than with ADH* 
cytosol, whereas NADPH-dependent rates o f p-aminophenol formation catalyzed by 
cytosol from ADH* and ADH* deermice were essentially equivalent (Fig. 2.IB).
The time courses for the reduction reactions are shown in Figure 2.2, where it is 
seen that p-aminophenol formation catalyzed by cytosol from ADH* deermice (panel A) 
is linear for up to 15 minutes with either of the cofactors. However, with NADH (filled 
triangles) the reaction clearly plateaus more abruptly than it does with NADPH (open 
triangles). The initial velocity o f  the NADH-dependent reaction, taken at ten minutes, 
is about two times greater than the NADPH-dependent reaction (44 ± 6  vs. 24 ± 4 
nmol/min/mg, respectively). With cytosol from ADH deermice (panel B), p- 
aminophenol formation was linear up to 30 minutes and, reminiscent o f  DCPIP 
reduction, specific activities were essentially identical with either NADH or NADPH
17
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(13.4 ± 0.4 vs. 13 ± 0.6 nmol/min/mg, respectively). The patterns ofp-nitrosophenol 
reduction by ADH* deermouse cytosol are similar to those reported previously by our 
laboratory for cytosol from male Sprague-Dawley rats (48).
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Fig. 2.1 Effect o f  varying the protein concentration on NADH- (A) and NADPH- (B) 
dependent formation of p-aminophenol from p-nitrosopheno 1 by deermouse cytosolic 
fractions. Increasing concentrations o f cytosol from ADH* (closed triangles) and ADH~ 
(open triangles) were incubated in the presence ofp-nitrosopheno 1 as described under 
Materials and Methods. Each data point represents the mean ± SD o f at least three 
experiments nm in triplicate with cytosol pooled from 4 animals from each treatment 
group.
2.3.3 Effect of Inhibitors on p-Aminopheno! Formation by ADH* Deermouse 
Cytosol
To evaluate the role o f certain enzymes in the cytosolic fractions o f the ADH* 
deermouse that might participate in the reduction o f  p-nitrosopheno 1 to p-aminophenol, 
the effects o f classical inhibitors o f putative nitroso reductases present in liver cytosol
18
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Fig. 2.2 Effect o f  NADH and NADPH on p-aminophenol formation from p- 
nitrosophenol by deermouse cytosolic fractions. Cytosol from ADH* (A) and ADH* (B) 
deermice was incubated in the presence ofp-nitrosophenol for time periods ranging from 
0-60 min as described under Materials and Methods. Rates for the NADH-dependent 
(closed triangles) and NADPH-dependent (open triangles) C-nitroso reductase activities 
are shown. Each data point represents the mean ± SD o f at least three experiments run in 
triplicate with cytosol pooled from 4 animals from each treatment group.
were studied. The inhibitors employed were: allopurinoL which forms an irreversible 
complex with the molybdenum center o f xanthine and aldehyde oxidase (62); 
dicumarol, a potent inhibitor of NAD(P)H: quinone oxidoreductase (60); and pyrazole, 
which forms a "dead-end" complex with ADH (63). Prior to using these inhibitors for 
our cytosolic studies preliminary experiments were conducted to establish their 
inhibitory effects on p-nitrosophenol reduction by purified NAD(P)H: quinone
19
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oxidoreductase, ADH and xanthine oxidase. At the concentrations employed dicumarol 
inhibited p-nitrosopheno 1 reduction by NAD(P)H: quinone oxidoreductase by greater 
than 80% and pyrazole inhibited purified horse liver and human P2 P2 -ADH (both class I 
ADH) by greater than 90%, (data not shown). Purified xanthine oxidase did not 
catalyze p-nitrosophenol reduction.
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Fig. 2.3 Effect o f pyrazole and dicumarol on NADH-dependent formation o f  p- 
aminophenol from p-nitrosophenol by cytosol from ADH+ deermice. Cytosol from 
ADH* deermice was incubated in the presence ofp-nitrosophenol for time periods 
ranging from 0-60 min as described under Materials and Methods. Final concentrations 
in 2 ml were: Pyrazole, 5 mM (closed triangles) and Dicumarol, 15 pM (closed squares). 
Control values are represented by the open squares. INSET: Effect o f inhibitors on 
NADPH-dependent p-aminophenol formation from p-nitrosophenol by cytosol from 
ADH* deermice (data shown for a 15 min incubation period). CON, Control; DC, 
Dicumarol; PYR, Pyrazole. Each data point represents the mean ± SD o f at least three 
experiments run in triplicate with cytosol pooled from 4 animals from each treatment 
group.
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The effects o f the inhibitors were significantly dependent upon the pyridine 
nucleotide cofactor employed in the reaction. Figure 2.3 shows pyrazole (5mM) to be 
an effective inhibitor (85-90%) o f the NADH-dependent C-nitroso reductase activity o f 
cytosol from ADH* deermice over the entire time course studied. Thus, this activity 
appears to be attributable to cytosolic ADH. With NADPH the inhibition by pyrazole 
was less than 20% and not statistically significant (Fig. 2.3 inset; shown for 15 min time 
point only). Dicumarol had little effect on the NADH-dependent reaction thus, 
NAD(P)H: quinone oxidoreductase does not appear to have a significant role in NADH- 
dependent reduction o f p-nitrosophenol by these cytosolic preparations. In  contrast to 
the nominal effect o f dicumarol on NADH-dependent activity the NADPH-dependent 
reaction was inhibited by greater than 90% (Fig. 2.3 inset). Allopurinol, at 
concentrations (20-200 pM) that potently inhibit the formation o f urate from 
hypo xanthine catalyzed by 0.15 units o f purified xanthine oxidase, was without effect 
on NADH- or NADPH-dependent activities, which indicates that neither cytosolic 
xanthine oxidase nor aldehyde oxidase are likely to be involved in the cytosolic 
reduction o f p-nitrosophenol (data not shown) under the conditions in which these 
experiments were conducted.
We considered the possibility that the insensitivity ofp-nitrosophenol reduction 
by ADH* and ADH* cytosol to allopurinol was due to failure to see an appropriate 
product contribution from xanthine oxidase activity under aerobic conditions. An 
identical experiment was conducted under nitrogen atmosphere to determine if the 
contribution o f  xanthine oxidase could be enhanced and therefore visualized under 
anaerobic conditions and, if so, whether the enhanced activity was aUopurino 1-sensitive.
21
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The results showed that p-nitrosophenol reduction by AD FT cytosol was increased by 
97% and by ADH' cytosol by 60% under a nitrogen atmosphere. In both instances the 
increase in activity was insensitive to allopurinol. Thus, it appears that the increase in 
activity under nitrogen atmosphere is due to enzymes other than xanthine oxidase, 
which does not seem to have a role in p-nitrosophenol reduction by cytosol from either 
AD FT or ADH' deermice whether oxygen is present or not.
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Fig. 2.4 Effect o f pyrazole and dicumarol on NADPH-dependent formation o f p- 
aminophenol from p-nitrosophenol by cytosol from ADFT deermice. Cytosol from AD FT 
deermice was incubated in the presence o f p-nitrosophenol for time periods ranging from 
0-60 min as described under Materials and Methods. Final concentrations in 2 ml were: 
Pyrazole, 5 mM (closed triangles) and Dicumarol, 15 pM (closed squares). Control values 
are represented by the open squares. INSET: Effect o f  inhibitors on NADH-dependent p- 
aminophenol formation from p-nitrosophenol by cytosol from ADFT deermice (data shown 
for a 15 min incubation period). CON, Control; DC, Dicumarol; PYR, Pyrazole. Each 
data point represents the mean ±  SD of at least three experiments run in triplicate with 
cytosol pooled from 4 animals from each treatment group.
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2.3.4 Effect of Inhibitors on ADH' Deermouse Cytosol
Whereas a significant cofactor preference was observed in the ADH* deermouse 
model with respect to C-nitroso reductase activity, this was not the case with cytosolic 
fractions from ADH* deermice; NADH- and NADPH-dependent activities were 
essentially equivalent (Fig. 2.4). Neither pyrazole nor allopurinol (not shown) 
significantly inhibited the rates o f formation o f  p-aminophenol from p-nitrosophenol. 
However, with either o f  these co factors, dicumarol potently inhibits reduction ofp- 
nitrosophenol; the NADH-dependent reaction is shown for the IS min time point only 
(Fig. 2.4 inset). Thus, the reduction o f p-nitrosophenol by this ADH-deficient cytosolic 
fraction appears to be mainly catalyzed by NAD(P)H: quinone oxidoreductase. We 
note that at the concentrations o f the inhibitors employed virtually no cross-reactivity 
was observed between these inhibitors and the enzymes probed in their respective 
purified forms. For example, 15 pM dicumarol was without effect on C-nitroso 
reduction by purified ADH from horse liver and xanthine oxidase from buttermilk, but 
did potently inhibit menadione and C-nitroso reduction by purified NAD(P)H: quinone 
oxidoreductase from rat liver (not shown).
2.3.5 NAD(P)H Oxidation by Deermouse Cytosol
ADH-dependent rates o f NAD(P)H oxidation catalyzed by the two deermouse 
cytosolic fractions in the presence o f the C-nitroso substrate were also determined to 
confirm the results obtained for the formation o f  p-aminophenol. These data are 
summarized in Table 2.1. Consistent with the data on p-aminophenol formation the rate 
o f NADH oxidation in the presence o f  p-nitrosophenol was about twice that o f NADPH 
oxidation with ADH* cytosol (77 ± 6  vs. 36 ± 1 nmol/min/mg). With ADH" cytosol the 
rates of NADH and NADPH oxidation were similar (71 ± 3  vs. 62 ± 5 nmol/min/mg).
23
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Pyrazole inhibited NADH oxidation catalyzed by ADH* cytosol by about 70% (77 ± 6  
to 22 ± 3 nmol/min/mg) and not that catalyzed by ADH' cytosol (59 ± 4  vs. 62 ± 5 
nmol/min/mg). Dicumarol inhibited the NADH-dependent ADH* and ADH* cytosolic 
reactions by 51% and 85%, respectively. Results o f the NADPH-dependent reaction 
were as expected, as the majority o f  NADPH oxidation catalyzed by ADH* and ADH* 
cytosol was highly dicumarol-sensitive and nominally pyrazole-sensitive. NADPH 
oxidation by ADH* and ADH* cytosol was inhibited by dicumarol by approximately 
80%, (from 36 ± 1 to 7 ± 2 and 71 ± 3 to 13 ±  1 nmol/min/mg by ADH* and ADH* 
cytosol, respectively).
Table 2.1 ADH-dependent NAD(P)H oxidation by deermouse cytosolic fractions.
nmol NADfPlH oxidized/min/me cvtosolic Drotein
ADH* ADH*
NADH
Control 77 ± 6 * 62 ± 5
+Pyrazole 22 ± 3 [7l%] 59 ± 4 [5%]
+Dicumarol 38 ± 2  [51%] 9 ± 1 [85%]
NADPH
Control 36 ±1 71 ± 3
+Pyrazole 28 ± 2  [2 2 %] 70 ± 3 [1%]
+Dicumarol 7 ± 2 [81%] 13 ± 1 [82%]
Oxidation o f NAD(P)H was monitored spectrophotometrically at 330 nm as described 
in Materials and Methods. (,)results represent means ± SD o f triplicate determinations 
on cytosolic fractions pooled from four animals from each group. ^V alues in brackets 
represent percent inhibition relative to uninhibited controls. Pyrazole and dicumarol 
concentrations are 5 mM and 15 pM, respectively.
24
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2.4 Discussion
The present study confirms in another mammalian species previous data from 
our laboratory that showed that cytosolic NADH-dependent p-nitrosophenol reduction 
is predominantly pyrazole-sensitive, which suggests that this C-nitroso reductase 
activity is associated with ADH in the liver (48). In fact, 5 mM pyrazole was 
significantly more effective as an inhibitor ofp-nitrosophenol reduction by ADIT 
deermouse cytosol (85-90%) than that by rat liver cytosol (50-60%; see ref. (48)). 
Moreover, the present studies with the ADH-negative deermouse extend our earlier 
findings to show that non-ADH metabolism o f a model C-nitroso substrate is apparently 
associated predominantly with liver cytosolic NAD(P)H: quinone oxidoreductase; this 
was true o f both the NADH- and NADPH-dependent activities. In the ADH" system 
NADH-dependent activity was as sensitive to dicumarol as was the NADPH-dependent 
activity, a result that is consistent with the equal affinity o f NAD(P)H: quinone 
oxidoreductase for the two pyridine nucleotides. The higher specific activity o f 
NAD(P)H: quinone oxidoreductase in the ADH' animal renders the contribution of this 
enzyme approximately equivalent to that o f the ADH* animal. Whether or not this is a 
compensatory action remains to be established. Nevertheless, ADH apparently was 
able to out compete the quinone oxidoreductase in the ADH* cytosol for p- 
nitrosophenol substrate when NADH was used as the cofactor.
Under the experimental conditions used herein, cytosolic C-nitroso reductase 
activity o f neither the ADH* nor ADH' animals was sensitive to allopurinol, even at 
concentrations that inhibited urate formation from hypo xanthine by purified commercial 
xanthine oxidase or cytosol by greater than 90% (not shown). Thus, under aerobic 
conditions liver cytosolic xanthine oxidase from ADH* or ADFT deermice (and more
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than likely aldehyde oxidase) does not catalyze reduction o f p-nitrosophenol to the 
amine. One possibility which might explain the apparent lack of a role for xanthine 
oxidase as a cytosolic C-nitroso reductase in the rat (48), and presently the deermouse, 
is that in contrast to ADH and NAD(P)H: quinone oxidoreductase, xanthine oxidase 
involves univalent reduction of nitro and nitroso substrates to oxygen labile free radical 
intermediates (64). Thus, rapid loss o f the free electron o f  the radical intermediate to 
molecular oxygen can be envisaged, which precludes formation o f further reduced 
products (65). Under aerobic conditions in the presence o f p-nitrosophenol and purified 
xanthine oxidase NADH oxidation was very slow and no faster than in the absence ofp- 
nitrosophenol (not shown). This would indicate that p-nitrosophenol is not a suitable 
acceptor o f electrons from xanthine oxidase. I f  a redox cycle was being mediated via a 
free radical intermediate o f p-nitrosophenol in the manner described above, a 
stimulation in the rate o f  NADH oxidation relative to the rate catalyzed by the xanthine 
oxidase in the absence ofp-nitrosophenol should have resulted. Furthermore, even in a 
nitrogen atmosphere, which did enhance p-aminophenol formation from p- 
nitrosophenol, allopurinol was without effect.
Both microsomal and cytosolic enzymes are involved in the metabolism o f  nitro 
and nitroso arenes (33, 65, 6 6 ). The equilibrium between the nitroso and 
hydroxylamine intermediates is an important consideration in the mutagenic expression 
o f arylamines and nitro arenes (38) because the hydroxy lamine is the precursor o f  the 
highly electrophilic arylnitrenium ion, which reacts strongly with nucleophilic centers 
o f DNA. The results o f  kinetic studies indicated the transient formation o f an enzyme-
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bound intermediate of />-nitro so phenol by 2 -electron transfer from one molecule o f
NADH (45).
Cytosolic NAD(P)H: quinone oxidoreductase is a major inducible nitro and 
nitroso reductase (67); it is induced by polychlorinated biphenyls (PCB, (67)), 
polynuclear aromatic hydrocarbons (6 8 ) and ethanol (48). ADH is not induced by 
exposure to these xenobiotics, therefore the contribution of NAD(P)H: quinone 
oxidoreductase to cytosolic C-nitroso reduction would be expected to be enhanced 
when it is induced. Under these experimental conditions, the induction o f  liver 
cytosolic NAD(P)H: quinone oxidoreductase upon pretreatment o f rats with the PCB
mixture Aroclor-1254® was nearly 20-fold over non-treated controls (67). When the 
effects o f pyrazole and dicumarol on NADH-dependent cytosolic nitro so phenol 
reduction was compared in control and PCB-induced rats the inhibition pattern in the 
controls were similar to that reported herein for ADFT deermice and in PCB-induced 
rats pyrazole inhibition was only about 10-15% and dicumarol inhibition about 85-90% 
(unpublished results).
The reduction o f a nitro group to the amine involves transfer o f  six electrons. 
Thus, aside from possible conjugated products, e.g. acetylated, etc. there are five 
potential intermediates o f nitroarene reductive metabolism. These include, the nitroso 
and hydroxylamine intermediates and three free radical species, the nitro anion, the 
nitroxyl and the aminoxyl radicals. The radical intermediates could either bind to 
nucleophilic centers of tissue macromolecules or lose the free electron to molecular 
oxygen thereby producing various oxygen radicals via a redox cycle. We have noted 
that neither NAD(P)H: quinone oxidoreductase purified from rat liver nor ADH purified
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from horse liver enhance the rates o f oxygen consumption or NAD(P)H oxidation in the 
presence of nitronapthalene or 4-nitroquinoline N-oxide (69), whereas these parameters 
are markedly increased by purified cytochrome P4S0 reductase and xanthine oxidase. 
Thus, it does not appear that the reduction o f C-nitroso substrates catalyzed by ADH or 
NAD(P)H: quinone oxidoreductase results in significant production o f  radical 
intermediates.
The results o f this study, in conjunction with those o f others cited herein, 
suggest a complex interplay o f  cytosolic enzymes in the metabolism o f  nitro and 
nitroso arenes. This complexity is in part related to the content o f  the enzyme in the 
liver and availability and redox status o f pyridine nucleotide co factors in the cytosolic 
fraction, both o f which are subjected to alteration by xenobiotic exposure. Further, it is 
likely that intermediates o f a primary or secondary reaction can shift loci, for example, a 
nitroaromatic might first be reduced by NAD(P)H: quinone oxidoreductase or xanthine 
oxidase and the resulting nitroso product might preferentially be further reduced by 
ADH. Certainly a great deal more investigation is required before the metabolic 
sequelae o f biotransformation o f  nitro or nitroso arenes to DNA adduct formation is 
elucidated with precision.
28
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 3 REDUCTION OF P-NITROSOPHENOL BY ALCOHOL
DEHYDROGENASE: COMPARISON OF HUMAN AND HORSE 
LIVER ISOZYMES
3.1 Introduction
Alcohol dehydrogenase (ADH, EC 1.1.1.1) is the primary enzyme responsible 
for the oxidation o f ethanol, with the production o f acetaldehyde and NADH being the 
first step o f  ethanol elimination (1). The reaction follows an ordered bi bi mechanism in 
which the binding of the co factor NAD* near the enzyme active site precedes binding o f 
substrate. This binary complex then binds one molecule of ethanol to form the 
catalytically active ternary complex. Catalysis occurs by hydride transfer from ethanol 
to the bound cofactor followed by the ordered release o f acetaldehyde and NADH. This 
reaction is reversible with the ADH-catalyzed reduction o f  acetaldehyde resulting in the 
production o f ethanol.
Mammalian zinc-containing ADH constitute an enzyme family o f  multiple 
isoforms. Horse liver alcohol dehydrogenase (HLADH) is the most widely studied. 
HLADH is composed o f two 40 kDa monomers, each containing 374 amino acids and 
two zinc ions, one having a structural function and the other a  catalytic function (70,
71).
Humans express more than 20 ADH isozymes composed o f as many as nine 
different subunits (4). The horse enzyme shares between 60% and 87% sequence 
identity with the human isozymes. Having been differentiated into five classes based on 
their genotypes, electrophoretic mobilities and inhibition by pyrazole and some o f  its 4- 
alkylated derivatives, the inter-class differences between the human isozymes are large 
and affect charge, enzyme activity, and inhibition patterns. The overall residue identity 
shows 60% homology between classes; many residues at the active site differ especially
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in the substrate-binding pocket, which is large and hydrophobic in the traditional 
ethanol-active liver enzyme o f class I, but different in the enzymes of the other classes.
Genes at three loci, ADH 1, ADH 2, and ADH 3, code for the class I isozymes 
a-, P-, and y-ADHs, respectively, with allelic variants o f  P and y (5, 6 ). These 
molecular forms are effectively inhibited by 4-methylpyrazole. Primary and secondary 
alcohols are almost equally good substrates for class I ADHs. Patterns o f class I 
isozymes also vary because of allelic polymorphism within and among different racial 
groups. Variants involving the p subunit have been designated Pi (Caucasian), P2 
(Oriental), and P3 (African) (6 ). Class II and class III each consist solely o f  one 
isozyme, tt-ADH and x*ADH, respectively, which are relatively insensitive to pyrazole 
inhibition. Class II ADH, translated by ADH 4, acts on primary aliphatic alcohols and 
aromatic aldehydes (7). All human isozymes catalyze the oxidation of ethanol; 
however, the Km o f  class II ADH for ethanol is significantly higher than that o f  class I 
forms. O f the vertebrate ADHs that have been identified, only one form, class III ADH, 
has been conserved in all organisms (8 ). Class HI ADH functions in vitro as a 
glutathione-dependent formaldehyde dehydrogenase, which suggests that this was the 
original function that drove the evolution o f  ADH (10). Class III is produced from the 
ADH 5 gene. The n  and % subunits share about 60% sequence identity with each other 
or the other isozymes and have not been observed to form heterodimers. Class IV is 
encoded by the ADH 7 locus that expresses the ct-ADH. Found predominately in the 
stomach, ct-ADH is considered to have a  significant role in retinol metabolism and first- 
pass ethanol metabolism (11-13). As with HLADH, these medium chain
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dehydrogenases are dimeric 80kd NAD+- and zinc-dependent ADHs, containing 4 zinc 
atoms per dimer (14, 15).
Microsomal and cytosolic enzymes are involved in the metabolism o f mutagenic 
nitro arenes and arylamines (33, 34). Arylamines are synthetic industrial compounds. 
Much research has been undertaken to understand the toxic sequelae o f arylamines (6 6 ,
72). Previous studies have shown that the mutagenic activation of 2-amino fluorene, a 
benchmark mutagenic arylamine, is lowered by liver microsomal fractions from 
ethanol-fed rats, but increased by the corresponding cytosolic fraction, when compared 
to pair-fed controls (6 6 ). Nitroarenes are ubiquitous, anthropogenically-generated 
contaminants formed predominantly by incomplete combustion (38). They have been 
detected in gasoline emissions, fly ash, cigarette smoke, grilled foods, incinerator 
emissions, residential home heaters and wood burning stoves (38, 39).
Dunn and Bernhard (1971) reported the reduction ofp-nitroso-N,N- 
dimethylaniline by horse liver ADH (40). It was noted that the nitroso moiety is both 
isosteric and isoelectronic with aldehyde functionality. Activation of nitroaromatic 
compounds to mutagens involves formation o f partially reduced metabolites, such as C- 
nitroso- or hydroxylamino compounds (67). The mutagenicity o f nitroarenes and 
arylamines is closely related to the steady-state concentrations o f the nitroso and 
hydroxylamino intermediates produced during their respective reductive and oxidative 
metabolism (54, 55). The potent mutagenic and carcinogenic potential o f nitro- and 
nitroso arenes is widely accepted to involve their facile reduction to N- 
hydroxy arylamines.
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ADH catalyzes both the reduction o f  2-nitrosofluorene and the rearrangement o f 
N-hydroxy-2-aminofluorene, which provides cogent evidence for the production o f  the 
electrophilic intermediate arylnitrenium ion (36). Moreover, NADH-dependent C- 
nitroso reductase activity catalyzed by both ADH-positive deermouse cytosol and rat 
liver cytosol is inhibited more than 85% by pyrazole, thereby implicating ADH as an 
important catalyst in these cytosolic fractions. (48, 73). Leskovac et al. have reported 
the metabolism of/>nitroso-N,N-dimethylaniline by yeast ADH and the HLADH 
catalyzed reduction ofpNSP (74, 75). Although ADH has been known to catalyze the 
reduction o f the C-nitroso functional group to its corresponding hydroxylamine for 
nearly two decades, the to xico logical ramifications o f this reaction had not been fully 
explored until recently (36, 37,48, 73). To implicate a role for the various human ADH 
in the toxicity o f  C-nitroso compounds we compared the activities o f purified human 
ADH isozymes with respect to the model C-nitroso substrate pNSP. The results were 
compared with those o f  purified HLADH, a benchmark ADH in biochemical studies. 
Evidence is presented to show distinctly different mechanisms and kinetics ofpNSP 
reduction by these different ADH isozymes.
3.2 Materials and Methods
3.2.1 Chemicals and Enzymes
Pyrazole, NADH, NADPH, benzaldehyde and potassium ferricyanide were 
obtained from Sigma (St. Louis, MO). pAP, /?NSP, and phenol were obtained from 
Aldrich Chemical Co. (Milwaukee, WI). Crystalline HLADH was obtained from 
Boehringer-Mannheim (Indianapolis, IN). All other chemicals were o f the highest 
grade commercially available. Purified human liver ADH isozymes were generously
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provided for these studies by Dr. W. F. Boston, Department o f  Biochemistry and 
Molecular Biology, Indiana University School o f  Medicine.
3.2.2 Preparation of Cytosolic Fractions
Human liver obtained from a normal Caucasian female human liver autopsy 
sample was generously provided by Dr. Sanda Clejan (Department o f Pathology,
Tulane University Medical Center, New Orleans, Louisiana). The cytosolic fraction 
(105,000 x g supernatant) of this human liver sample was prepared by differential 
centrifugation o f  liver homogenates according to standard techniques in the literature 
(59). Fractions were aliquoted and stored at -80°C prior to use.
3.2.3 Enzyme Assays
Formation ofpAP from pNSP was determined essentially by the method o f 
Horie et al. (44) with modifications (48). pNSP (0.05-ImM) was incubated for 15 
minutes in the presence o f200 pM NADH or NADPH and approximately 0.05 mg/ml 
cytosolic protein or 1 pg/ml purified HLADH or 0.7-1 pg/ml purified human ADH in 
50 mM potassium phosphate buffer or 0.1 M MES, 51 mM NEA, 51 mM DEA, pH 7.4, 
in a final volume o f  2 ml. The reaction was initiated by addition of cofactor and 
terminated by addition o f 300 pi o f  1 M NaaCCh. pAP formation was detected 
spectropho to metrically by subsequent addition o f 300 ml o f  5% (w/v) aqueous phenol 
and 200 ml o f  0.2% (w/v) potassium ferricyanide. The color was allowed to develop 
for at least 15 min and the absorbance was read at 630 nm against a reagent blank. The 
concentration ofpA P formed was calculated from a standard curve using commercially 
available pAP. Additional reactions contained 15 mM dicumarol, 5 mM pyrazole, or 20 
mM allopurinol. The extent ofpN SP reduction was determined spectrophotometrically 
by tracing the loss o f  absorbance at 400 nm. The enzyme-catalyzed reaction was
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quantified using the extinction coefficient o f  pNSP, 6 4 0 0 = 21.92 mM' * cm ' 1. Spectral 
transition studies were determined in tandem cuvettes. The two chambers o f  the sample 
cuvette contained: 1) 50 mM potassium phosphate buffer, pH 7.4, and 2) 120 pM 
pNSP, 200 pM NADH, 50 mM potassium phosphate buffer, pH 7.4, and purified ADH 
in a final volume o f 1 ml. Those o f the reference cuvette contained: 1) 200 pM NADH, 
50 mM potassium phosphate buffer, pH 7.4,and purified ADH, and 2) 120 pM pNSP 
and 50 mM potassium phosphate buffer, pH 7.4, in a final volume o f 1 ml. The 
reactions were initiated with addition o f  the enzyme. Reactions were followed 
spectro photo me trical ly at 1-1.5 min intervals for 15 min time periods. ADH activities 
were measured by the method o f  Bonnichsen et al. (61), which is based on 
spectrophotometric measurement o f NADH formation from NAD+ in the presence o f 
ethanol. All spectrophotometric measurements were performed with a Hitachi U-3110 
UV-visible spectrophotometer at 25°C.
Quinone reductase activity by ADH was determined by a modification o f the 
procedure described by Emster et al. (76) for NAD(P)H: quinone oxidoreductase (DT- 
diaphorase). 1,4-Benzoquinoneimine (BQI) was synthesized by Dr. Zofia Maskos in 
our laboratory by oxidation of/?AP in CH3CN in the presence o f AgaO at room 
temperature as described by Novak and Martin (77). The reaction mixture contained 
0.05 M phosphate buffer, pH 7.4,0.2 mM NAD(P)H and 32 mM BQI. The reaction 
was followed by recording the reduction o f  BQI at 262 nm (£262= 28.2 mM" 1 cm*1) and 
the oxidation o f  NADH at 340 nm (£340= 6.22 mM*1 cm'1).
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3.3 Results
3.3.1 Effect of Inhibitors on NADH-Dependent p-Aminophenol Formation by 
Human Liver Cytosol
As a first approach to evaluating a role for the various NADH-linked enzymes in 
the cytosolic fractions o f human liver that might participate in the reduction o f pNSP to 
p-aminophenol (pAP), the effects o f  classical inhibitors o f putative nitroso reductases 
present in liver cytosol were studied (Fig. 3.1). The inhibitors employed were 
allopurinol, which forms an irreversible complex with the molybdenum center of 
xanthine (EC 1.1.3.22) and aldehyde (EC 1.2.3.1) oxidase (62); dicumarol, a potent 
inhibitor o f NAD(I>)H:quinone oxidoreductase (60); and pyrazole, which forms a 
“dead-end” complex with some ADH isozymes and NAD+ (63).
Cytosol prepared from a normal female human liver autopsy sample catalyzed 
NAD(P)H-dependent reduction o f  pNSP (Fig. 3.1). As was reported for this activity 
catalyzed by cytosol from rat liver and ADH-positive deermouse liver (48, 73), NADH- 
dependent pNSP reduction catalyzed by human liver cytosol was sensitive to inhibition 
by pyrazole. These experiments showed that 5 mM pyrazole potently inhibited (> 90%) 
the NADH-dependent formation o f  pAP from pNSP; this inhibition was actually greater 
than that caused by pyrazole on the cytosolic reduction o f pNSP by the rodent liver 
cytosols, which were 75% and 85%, respectively (48, 73). Thus, this activity appears to 
be attributable to cytosolic ADH. Dicumarol inhibited the NADH-dependent reaction 
by only 7%; thus, NAD(P)H:quinone oxidoreductase does not appear to have a 
significant role in NADH-dependent reduction o f pNSP. NADPH-dependent activity 
was potently inhibited by dicumarol in rodent and human liver cytosol. Unexpectedly, 
and in direct contrast to rodent liver cytosol, pyrazole inhibited the NADPH-dependent
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reduction o f  pNSP by human liver to about 80%. In agreement with our studies o f 
deermouse and rat liver cytosols, aliopurinol inhibited neither NADH- nor NADPH- 
dependent pAP formation by human liver cytosol Pyrazole also inhibited the NADH- 
dependent activity o f  purified horse liver by greater than 90% and the NADPH- 
dependent activity by about 30% (Figure 3.2).
12
■  NADH 
□  NADPH
Control Pyrazole Dicumarol Aliopurinol
SnM  15 iiM  20
Inhibitors
Fig. 3.1 Effect o f  Inhibitors on NADH-dependent pA P formation by HLC. Reaction 
conditions are: 50 mM phosphate buffer, pH 7.4; 0.2 mM NADH; 120 pM pNSP; and 
0.05 mg/ml cytosolic protein. Data shown for 15 min time point and is the result of 
triplicate determinations.
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■  NADH 
□  NADPH
Control Pyrazole Die tuna rol Aliopurinol
5 mM 15 pM 20 pM
Inhibitors
Fig. 3.2 Effect o f  Inhibitors on NAD(P)H-dependent pAP  formation by HLADH. 
Reaction conditions are: 50 mM Potassium phosphate, pH 7.4; 0.2 mM NADH; 120 
pM pNSP; and 2.5 pg/ml HLADH. Data shown for 15 min time point and is the result 
o f triplicate determinations.
3.3.2 NADH-Dependent pNSP Reduction by HLADH and Purified Human ADH 
Isozymes: Effect of Pyrazole
Because NADH is the preferred cofactor for ADH-catalyzed C-nitroso reduction 
further studies were done only with respect to NADH-dependent activity. Figure 3.3 A 
& B shows the time courses o f NADH-dependent C-nitroso reductase activity o f 
purified human ADH representatives o f classes I - IV and HLADH. The graphs 
illustrate the formation of pAP  over a period o f  60 min, except in the case o f  the human
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Fig. 33A  NADH-dependent pNSP reduction by HLADH and purified human 
isozymes: Effect o f pyrazole. Reaction Conditions: In 2 ml, 50 mM Potassium 
phosphate, pH 7.4; 0.2 mM NADH; 5 mM pyrazole. (A) 1 pg/ml HLADH; 120 pM 
/?NSP. (B) 0.75 pg/ml aa-A D H ; 300 pM/?NSP. (C) 0.75 pg/ml pipi-ADH; 300 pM 
pNSP. (D) 1 pg/ml P2 P2-ADH; 300 pM />NSP. (E) 0.41 pg/ml x-ADH; 300pM pNSP 
(F) 0.7 pg/ml Jt-ADH; 120 pM pNSP. (G) 0.8 pg/ml tr-ADH; 300 pM pNSP.
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Fig. 3.3B NADH-dependent pNSP reduction by HLADH and purified human 
isozymes: Effect o f pyrazole. Reaction Conditions: In 2 mL, 50 mM Potassium 
phosphate, pH 7.4; 0.2 mM NADH; 5 mM pyrazole. (A) 1 pg/ml HLADH; 120 pM 
/>NSP. (B) 0.75 pg/ml aa-ADH; 300 pM pNSP. (C) 0.75 pg/ml PiPi-ADH; 300 pM 
pNSP. (D) 1 pg/ml P2P2-ADH; 300 pM pNSP. (E) 0.41 pg/ml x-ADH; 300pM pNSP. 
(F) 0.7 pg/ml ti-ADH; 120 pMpNSP. (G) 0.8 pg/ml o-ADH; 300 pM pNSP.
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class II 7t-ADH, where only a 30 min time course is presented. The data illustrate the 
marked differences in the metabolism ofpNSP by the various purified human ADHs 
and HLADH. Initial experiments were performed at a concentration of />NSP (120 pM) 
comparable to that used in our previous studies (48, 73). However, at this concentration 
o f pNSP, the class I, III, and IV ADH isozymes did not catalyze the formation o f pAP  at 
levels high enough to achieve quantifiable data at all o f  the time points studied; 
therefore, time courses with these isozymes were determined using 300 pM pNSP.
Class II x-ADH showed greater preference for the C-nitroso substrate than the class I 
a a - , P iP r, and P2 P2-, class ID x-, and class IV cr-ADHs. Pyrazole, which is a potent 
inhibitor o f  ethanol oxidation by class I ADH and a weak inhibitor o f that by class II n- 
ADH, potently inhibited pNSP reduction by class I P 1P 1-ADH and HLADH but not that 
by class I a a -  and P2 P2-ADH, class II, class HI and class IV ADH. NADH-dependent 
pNSP reduction by class I aa-ADH was linear for the entire time course studied and 5 
mM pyrazole inhibited this activity by 40% (Fig. 3.3A). The activities o f the human 
beta isozyme homodimers, P1P1 and P2P2, were linear for up to 60 min, however, they 
show varying degrees o f inhibition by pyrazole. pNSP reduction by the P 1P 1-ADH 
isozyme was inhibited 90% by 5 mM pyrazole whereas the P2 P2-ADH-catalyzed 
activity was inhibited by about 60%. As was seen for ethanol oxidation, pyrazole 
inhibition o f  the Class II 7t and Class HI x isozymes was negligible (< 5%). At 300 pM 
pNSP class IV a-ADH-catalyzed formation o fpA P  was linear for up to 20 min. 
Thereafter, product formation began to plateau, indicating that the concentration of 
pNSP had become limiting in the reaction. In this regard the pNSP concentrations are
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presumed to be below saturating in the reaction. The reaction catalyzed by class IV ct- 
ADH was inhibited 50% by pyrazole.
3.3.3 Determination of Steady-State Kinetic Constants for Acetaldehyde and pNSP 
Reduction via HLADH
Figure 3.4A shows a Lineweaver-Burk plot for/?NSP reduction by HLADH 
where pNSP concentrations were varied over a range o f 0.03-1.2 mM in the presence of 
a constant concentration o f  50 nM HLADH and 0.9 mM NADH. A similar plot was 
obtained for acetaldehyde (1.2-14.2 mM) reduction via 10 nM HLADH and 0.3 mM 
NADH (Fig. 3.4B). Calculated KM and VM)( values for each were determined using a 
statistical program described by Cleland (78) and are compared in Table 3.1. The 
catalytic efficiency (kcai/KM) o f  HLADH toward pNSP reduction was similar to its 
efficiency toward acetaldehyde reduction (2017 mM-1 min*1 vs. 2332 mM*1 min*1, 
respectively). However, the Km and V™, values for acetaldehyde reduction were at 
least three times greater than those obtained for pNSP reduction. The kinetic constants 
for the human ADH-catalyzed reduction o f  pNSP were determined for the class I a a -, 
P1P1-, and P2P2-, and the class II n-ADH isozymes. Each human isozyme appeared to 
be at least one order o f magnitude less efficient in catalyzing pNSP reduction than 
HLADH. The lower efficiencies are attributable to higher Km and lower V ,^  values 
associated with pNSP reduction.
3.3.4 Spectral Transitions During the Reduction of/?NSP by ADH Isozymes
As reported by Maskos and Winston (37) a unique feature o f HLADH-catalyzed 
reduction ofpNSP (Fig. 3.5) was the formation o f a spectral intermediate between 252 
and 261 nm, which arises concomitantly with loss o f  absorbance associated with the 
nitroso compound at 400 nm. This intermediate then decayed slowly, giving rise to an
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Fig. 3.4A Determination o f Kinetic Constants for pNSP and Acetaldehyde Reduction 
by HLADH. Reaction with 0.9 mM NADH in 50 mM phosphate buffer at pH 7.4. 
HLADH was present at 50 nM. Each data point represents the mean o f at least three 
experiments run in triplicate.
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Fig. 3.4B Determination o f  Kinetic Constants for pNSP and Acetaldehyde Reduction 
by HLADH. Reaction with 0.3 mM NADH in 50 mM phosphate buffer at pH 7.4. 
HLADH was present at 10 nM. Each data point represents the mean o f at least three 
experiments run in triplicate.
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Table 3.1 Kinetic constants for Horse Liver ADH towards pNSP and acetaldehyde at
PH 7.4.____________________________________________________________________
Km V™ Lc«/Km
(mM) (pmol/min/mg) mM min' 1
pNSP 0.52 13.11 2017
Acetaldehyde 1 . 6 8 48.98 2332
Kinetic constants for pNSP reduction via Human ADH isozymes at pH 7.4
K m
(mM)
V™
(pmol/min/mg)
L ii / K m  
mM *1 min' 1
aa-AD H 4.19 2.55 49
piPi-ADH 1 . 1 0 1 . 6 6 1 2 1
P2 P2-ADH 2 . 0 2 1.49 59
ti-ADH 2.19 4.84 177
X-ADH 0.70 1.46 168
ct-ADH 1.30 6.95 428
Reaction conditions were as follows: 50 mM Potassium phosphate buffer; 30-1270 pM 
pNSP; 1.25—15 mM Acetaldehyde; 2 mM NADH; 0.8-4 pg/ml HLADH; 2.3 pg/ml a a -  
ADH; 2.5 pg/ml PiPi-ADH; 3.3 pg/ml P2 P2-ADH; 1.9 pg/ml tr-ADH. Assays with x* 
and a-ADH were performed in 0.1 M MES, 51 mM NEA, 51 mM DEA, pH 7.4; 3.8 
p g / m l  x-ADH; 1.2 pg/ml ct- A D H .
absorbance due to pAP formation (232 nm). Neither HLC nor any o f the human ADH 
isozymes tested appeared to catalyze the formation o f this intermediate. The reaction 
catalyzed by human ADH indicated that the decay ofpNSP at 400 nm and NADH at 
340 nm is associated with the formation ofpA P with an absorbance maximum at 232 
nm (Fig. 3.5). The maxima associated with the intermediate at 252 and 261 nm in the 
HLADH catalyzed reaction are characteristic o f  the observed spectrum o f 1,4- 
benzoquinoneimine (BQI) (77). Maskos and Winston (37) have proposed two distinct
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Fig. 3.5A Changes in absorption spectra during the reduction o f  pNSP by HLADH. 
Time interval between scans is 1 min. Reaction Conditions: 50 mM Potassium 
phosphate, pH 7.4 in lml; 0.1 mM pNSP, 0.1 mM NADH. Enzyme concentration: 20 
pg/ml HLADH. Graph was reprinted from Maskos and Winston, 1994 (37).
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Fig. 3.5B Changes in absorption spectra during the reduction o f pNSP by rc-ADH. 
Time interval between scans is 1.5 min. Reaction Conditions: 50 mM Potassium 
phosphate, pH 7.4 in 1ml; 0.1 mM /?NSP, 0.1 mM NADH. Enzyme concentration: 25 
pg/ml tr-ADH. Graph was reprinted from Maskos and Winston, 1994 (37).
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Fig. 3.5C Changes in absorption spectra during the reduction of/>NSP by aa-AD H. 
Time interval between scans is 1.5 min. Reaction Conditions: SO mM Potassium 
phosphate, pH 7.4 in 1 ml; 0.1 mM pNSP, 0.1 mM NADH. Enzyme concentration: 15 
pg/ml aa-ADH.
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Fig. 3.5D Changes in absorption spectra during the reduction of/?NSP by PiPi-ADH. 
Time interval between scans is 1.5 min. Reaction Conditions: 50 mM Potassium 
phosphate, pH 7.4 in lml; 0.1 mM / jNSP, 0.1 mM NADH. Enzyme concentration: 39 
pg/ml Pi Pi-ADH.
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Fig. 3.5E Changes in absorption spectra during the reduction ofpNSP by P2P2-ADH. 
Time interval between scans is 1.5 min. Reaction Conditions: 50 mM Potassium 
phosphate, pH 7.4 in 1ml; 0.1 mM pNSP, 0.1 mM NADH. Enzyme concentration: 24 
p.g/ml P2 P2-ADH.
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Fig. 3.5F Changes in absorption spectra during the reduction o f pNSP by x-ADH. 
Time interval between scans is 2 min. Reaction Conditions: 50 mM Potassium 
phosphate, pH 7.4 in 1ml; 0.1 mM pNSP, 0.1 mM NADH. Enzyme concentration: 24 
pg/ml x-ADH.
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Fig. 3.5G Changes in absorption spectra during the reduction o f pNSP by ct-ADH. 
Time interval between scans is 1 min. Reaction Conditions: 50 mM Potassium 
phosphate, pH 7.4 in lml; 0.1 mMpNSP, 0.1 mM NADH. Enzyme concentration: 8  
pg/ml ct-ADH.
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Fig. 3.5H Changes in absorption spectra during the reduction o f  pNSP by HLC. Time 
interval between scans is 1.5 min. Reaction Conditions: 50 mM Potassium phosphate, 
pH 7.4 in 1ml; 0.1 mM pNSP, 0.1 mM NADH. Enzyme concentration: 0.38 mg/ml 
HLC.
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mechanisms for the metabolism ofpNSP by ADH isozymes dependent on the ability o f 
the individual enzymes to efficiently metabolize BQI.
Pursuant to the study o f  Maskos and Winston, we show the comparative 
activities o f  HLADH and various human ADH isozymes with respect to nitroso and 
benzoquinoneimine reduction and ethanol oxidation (Table 3.2). The rates for 
reduction o f pNSP and appearance ofpAP were calculated based on the change in 
absorbance at 400 and 232 nm, respectively, as seen in the spectral profiles. HLADH 
was considerably more active than the human isozymes as a pNSP reductase. The 
specific activity for reduction ofpNSP by HLADH was 1.53 pmol/min/mg, which was 
two times greater than that o f the most active human ADH. However, HLADH, which 
exhibits relatively poor activity as a benzoquinoneimine reductase (0 . 0 0 1  
pmol/min/mg), had a specific activity o f 0.218 pmol/min/mg fbr/?AP formation.
Table 3.2 Activity o f HLADH and Human ADH isozymes as ethanol oxidases, 
nitroso- and benzoquinoneimine reductases._______________________________
Ethanol
Oxidation
pNSP
reduction
1,4-Benzoquinoneimine pAP
reduction formation
nmol/m in/mg pmol/min/mg
HLADH 1.1 1.53 0.001 0.218
Human aa-ADH 1.43 0.707 0.369 0.635
Human pipi-ADH 0.12 0.027 0.012 0.025
Human P2P2-ADH 0.6 0.090 0.200 0.082
Human x-ADH 4.69 0.145 ND® 0.140
Human 7t-ADH 0.08 0.530 6.650 0.541
Human cr-ADH 40.0 0.189 No Activity 0.180
Reaction conditions were as follows: 50 mM phosphate buffer; 10 mM EtOH (6 mM 
Cinnamyl Alcohol with x-ADH); 120 pM pNSP; 32 pM BQI; 0.1-0.2 mM NADH; 25- 
50 pg/ml HLADH; 0.75-15 pg/ml aa-ADH; 22-93 pg/ml PiPi-ADH; 4.2-42 pg/ml 
P2P2-ADH; 1.9-48 pg/ml n-ADH; 0.45-2.7 pg/ml x-ADH; 8-22 pg/ml ct-ADH. Results 
represent mean o f triplicate determinations.
aActivity not determined.
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The specific activity o f  class I aa-AD H for the reduction ofpN SP was 0.707 
pmol/min/mg, which was higher than all other human isozymes tested. The relative 
order of specific activities for /?NSP reduction by these ADH isozymes was HLADH > 
a a  > 7i > ct >x > P2P2 > PiPi- The specific activity o f class I P2P2-ADH for ethanol 
oxidation was about 8  times higher than that o f class II x-ADH (0.6 pmol/min/mg vs. 
0.08 pmol/min/mg, respectively). Class II n-ADH is known to have a much lower 
ethanol oxidase activity than P2 P2-ADH (79). In contrast to ethanol oxidation, the 
specific activity o f  class II n-ADH for reduction of/?NSP was 6  times higher than that 
o f class I P2P2-ADH (0.53 pmol/min/mg vs. 0.09 pmol/min/mg, respectively). Class I 
aa-ADH catalyzed ethanol oxidation with activity similar to HLADH, i.e. 1.4 
pmol/min/mg vs. 1.1 pmol/min/mg, respectively. In the reactions catalyzed by human 
ADH, the rate o f pAP formation was almost identical to the rate o f  pNSP disappearance 
(0.6 vs. 0.7 pmol/min/mg, respectively, for aa-ADH). Thus, the second step o f the 
reaction, the reduction of benzoquinoneimine, does not appear to be rate limiting for the 
overall reaction. The rate of BQI reduction catalyzed by class II x-ADH was at least an 
order o f magnitude higher than all other ADH isoenzymes tested, which may indicate a 
role for x-ADH as a biological quinone reductase (37). Each of the human ADH 
isozymes showing BQI reductase activity catalyzed the reduction o f  BQI at least 2 
orders of magnitude foster than the corresponding rate for HL ADH-catalyzed BQI 
reduction. At first hand, a comparison o f the rates o f pNSP reduction versus the rates o f 
BQI reduction (Table 3.2) would indicate that the activities of class I a a -  and PiPi- 
ADH toward BQI were slightly lower than their corresponding activities toward pNSP. 
The concentration ofpNSP used in these reactions was 120 pM. Since the lowest Km
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value obtained for /?NSP with any o f  the human ADH isozymes was approximately 700 
pM, pNSP is subsaturating. At 32 pM the concentration o f BQI used in these reactions 
was also most likely not saturating; therefore, an increase in BQI concentration to levels 
used for pNSP would likely increase the rates o f its reduction. Thus, the rate o f  BQI 
reduction, the second reductive step, potentially could exceed that o f  pNSP reduction, 
the first reductive step o f  the reaction. In contrast, HLADH-catalyzed reduction o f  BQI 
was 3 orders o f magnitude lower than pNSP reduction, 0.001 pmol/min/mg vs. 1.53 
pmol/min/mg, respectively. Reduction o f BQI (32 pM) with class IV ct-ADH was not 
observed.
3.4 Discussion
Both microsomal and cytosolic enzyme activities are involved in the metabolism 
o f nitroaromatics and arylamines. Activation o f nitroaromatic compounds to mutagens 
involves formation of partially reduced metabolites, such as C-nitroso or 
hydroxylamino compounds, via nitroreduction (54, 55). Formation and removal o f  the 
nitroso intermediates o f arylamines and nitroaromatics is o f  the utmost importance in 
their mutagenic expression.
The objective o f  our previous studies was to determine the role o f ADH in the 
reductive metabolism o f C-nitroso compounds in cytosol where other C-nitroso group 
reducing enzymes are present simultaneously. In these studies pNSP was used as an 
aldehyde-substrate analog to compare the C-nitroso reductase activities o f several ADH 
isozyme representatives o f  the four major classes o f  ADH expressed in human liver and 
other tissues. In our previous studies with deermouse cytosol it was suggested that the 
metabolism of/?NSP involves a complex interplay o f cytosolic enzymes. Therefore, our
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approach to the study o f cytosolic C-nitroso reduction was to use assay specific enzyme 
inhibitors o f different putative C-nitroso reductases, Le. pyrazole, aliopurinol, and 
dicumaroL The rate o f NADPH-dependent C-nitroso reduction by cytosolic fractions 
was about 50% lower than the NADH-dependent rate; indicating that a substantial 
amount o f the C-nitroso reduction is due to NADH-dependent enzymes. Pyrazole 
inhibited NADH-dependent pNSP reduction by ADH-poshive deermouse cytosol by > 
85%. Thus, ADH appears to contribute substantially to NADH-dependent C-nitroso 
reduction. The NAD(P)H: quinone oxidoreductase inhibitor, dicumarol, inhibited 
NADH-dependent pAP formation from pNSP by about 25%; however, dicumarol 
potently inhibited the NADPH-dependent formation (90-95%). Similar results were 
also reported by Hajos and Winston for the rat cytosolic system (48).
Our experiments with human liver cytosol showed that pyrazole potently 
inhibited the NADH-dependent formation o f pAP from pNSP. This inhibition was 
more profound than that seen with rat liver cytosol. NADPH-dependent activity was 
potently inhibited by dicumarol and not inhibited by pyrazole. In agreement with our 
previous studies with deermouse and rat liver cytosols, aliopurinol did not inhibit either 
NADH- or NADPH-pAP formation by human liver cytosoL The data indicate NADH- 
dependent C-nitrosoreductase activity in human liver cytosol, as in rat and deermouse 
liver, as being associated mainly with alcohol dehydrogenase. Thus, NADH-dependent 
reduction ofpNSP by human liver cytosol behaves essentially identical to that observed 
in the rat and deermouse liver cytosols. Although NADPH-dependent pNSP reductase 
activity o f human liver cytosol was only about 15% o f  NADH-dependent activity, it 
was strongly inhibited by both dicumarol and pyrazole. NADPH can be used as a
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cofactor by certain ADH isozymes, albeit less efficiently than NADH (70, 80). Our 
data suggest the presence o f an ADH in human liver cytosol with preference for 
NADPH that is not present in the rodent cytosols studied, or the presence o f ADH that 
can use NADPH with similar efficiency as NADH. Supporting evidence o f significant 
NADH-dependent C-nitroso reduction due to ADH is the feet that purified HLADH 
presented the same general trends as those seen with the cytosolic preparations. 
HLADH catalyzed NADH-dependent reduction ofpNSP and was potently inhibited 
(90%) by 5 mM pyrazole.
ADH isozymes display wide variation in both substrate and inhibitor specificity 
(81). There are both inter- and intraclass differences in their substrate specificities (14, 
82, 83). Methanol, digitoxigenins, the glycol intermediates in norepinephrine 
metabolism, and the intermediary alcohols and aldehydes o f dopamine metabolism are 
substrates o f class I ADH (14, 82-84), while class II preferentially catalyzes benzyl 
alcohol/benzaldehyde oxidoreduction (14). Thus far, only long-chain aliphatic alcohols 
have been found to be good substrates o f class HI ADH (83). Purified class IV ADH 
exhibits the highest catalytic efficiency with long chain alcohols. It also exhibits 
activity with more complex alcohols such as all-frans-retinol. Therefore, it was not 
surprising that human ADH exhibited marked differences in the metabolism of/?NSP. 
Class II tt-ADH, which has a much lower preference for ethanol than the class I 
isozymes (79, 85), showed significantly greater efficiency in the reduction o f the C- 
nitroso substrate than the class I ADH. pNSP reduction by class I a a -  and P2 P2-ADH 
and class II tt-ADH inferred a lower affinity with these isozymes for the nitroso 
substrate as compared to HLADH, P 1P1-, x- and cr-ADH.
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Pyrazole, a potent inhibitor o f  ethanol oxidation by class I ADH and a weak 
inhibitor o f that by classes II and III, potently inhibited pNSP reduction by piPi-ADH 
but not that by n-ADH and x-ADH. The activity o f human n- and x-ADHs appeared to 
be relatively insensitive to inhibition by 5 mM pyrazole. Whereas, the activity o f  a a - ,  
P2P2- and ct- A D H  were inhibited by about 50%, PtPi-ADH is inhibited by about 90%. 
As the Pipi-ADH isoform is the predominate ADH found in the liver o f Caucasians, it is 
significant to note the similarities in the nitrosoreductase capabilities o f  this enzyme and 
HLC. Inhibition by pyrazole was similar between HLC and P 1P 1-ADH; both were 
inhibited by more than 90%. These results lend credence to the interpretation that the 
predominance o f C-nitrosoreductase activity in the cytosol is due to ADH.
The differences in the activities between ADH isozymes may be attributed to 
their distinctively different active site geometries. The inner part o f the substrate- 
binding pocket is formed by the zinc atom, its ligands, the nicotinamide ring o f NADH, 
and residues 48 and 93 (18). The class I aa-A D H  isozyme has the greatest overall 
structural identity with class I 0-ADH. However, their substrate binding pockets differ 
dramatically (8 6 ). For instance, the active she o f P1P1-ADH is narrow and restrictive 
near the catalytic zinc atom and can bind small substrates in relatively few 
conformations, thus increasing opportunities for productive bonds between the substrate 
and amino acid side chains o f the active she. The active site o f the aa-AD H isozyme 
cannot restrict the binding o f  small substrates and more non-productive bonds may be 
formed. The aa-ADH, having an Ala-93 substitution for the Phe-93 that is present in 
other class I, II, and IV ADH, exhibits a more spacious active site near the catalytic zinc 
atom and narrows as the distance from the zinc increases. In contrast to small substrates
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such as ethanoL, the increased volume o f the active site near the catalytic zinc atom of 
aa-A D H  may accommodate the phenol ring of/?NSP in a more productive orientation 
than can be accomplished with Pi Pi-ADH. Eklund et al. have reported that the active 
site o f  p,p,-ADH limits access to the catalytic zinc ion for bulky compounds such as 
benzyl alcohol and cyclohexanol (18), which are o f similar size and geometry as pNSP.
The preference o f class III x-ADH for larger substrates, as seen in its preference 
for cinnamyl alcohol over ethanol explains its ability to catalyze pNSP reduction at a 
rate more than twice that o f  the p iso forms, the predominate liver ethanol 
dehydrogenases. Cinnamyl alcohol has a phenyl ring bound to a propenol moiety. This 
preference may be due to a unique substrate binding site that encloses twice the volume 
o f the p ipi substrate binding site (8 6 ). While the inner portion o f  the active site in these 
isozymes is similar, the larger outer portion o f  the x*ADH active site may allow the 
phenol ring o f pNSP greater degrees o f movement and thus allow this substrate to 
achieve an orientation more conducive to catalysis.
The substrate-binding site o f  class IV cr-ADH is enlarged near the catalytic zinc 
ion and the middle region o f  the substrate-binding pocket is narrow. In general, cr-ADH 
catalyzed oxidation o f primary aliphatic alcohols presents increasing catalytic 
efficiencies as the chain length increases (4, 11). However, a-ADH shows different 
kinetic properties with more complex alcohols, such as steroid alcohols and secondary 
alcohols. Class IV ct-ADH is unable to oxidize bulky secondary alcohols efficiently. 
Likewise, while cr-ADH exhibits considerably greater activity as an ethanol oxidase, its 
activity is comparatively much lower than HLADH and n-ADH with respect to pNSP 
reduction. However, it has been shown that the cr-ADH generally exhibits greater
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efficiency catalyzing the reduction o f aldehydes (nitroso analogs) than corresponding 
alcohols at pH 7.5, having both lower Km and higher V„»x values (11). Aromatic 
compounds have also been shown to be good substrates for class IV a-ADH. The best 
substrate found so far for cr-ADH is m-nitrobenzaldehyde, having a Km and o f
41 pM and 135,000 mM-1 min*1, respectively (11). Benzaldehyde was also a good 
substrate with Km and kc/Kiu values o f430 pM and 6,900 mM*1 min*1, respectively. 
Given the structural similarity between these two aldehydes and pNSP, it is surprising 
that the a-ADH does not exhibit activities and efficiencies with the nitroso substrate 
(kct/KM = 428 mM ' 1 min*1) more comparable to the benzaldehyde substrate. This 
comparatively lower activity may indicate inhibitory secondary interactions o f the 
pNSP hydroxyl moiety with active site residues.
As in alcohol oxidation, the overall pNSP reduction rate is likely dependent on 
coenzyme-binding residues since the rate-limiting step in alcohol oxidation has been 
shown to be the dissociation o f NADH. The clearest example o f this is the difference in 
pNSP reduction rates between PiPi-ADH and P2 P2-ADH. These two class I P-ADH 
variants differ by only one residue in their substrate- and coenzyme-binding sites; Arg 
47 in Pi has been replaced by a His residue in p2 (6 ). Yet, P2 P2-ADH catalyzed pNSP 
reduction at a rate 4 times higher than that o f P 1P 1-ADH.
As the nitroso moiety is both isosteric and isoelectronic with aldehyde functionality, 
it was informative to compare the ADH catalyzed reductions o f pNSP and 
acetaldehyde. HLADH shows a three-fold higher Km and Vmix for acetaldehyde than 
for pNSP. In comparison, Leskovac et al. (75) showed similar results in that the V ^x 
values for pNSP and acetaldehyde were o f the same order o f  magnitude. It is o f more
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significance that the catalytic efficiency o f  the HLADH-catalyzed reduction o f  pNSP is 
virtually identical to that o f the reduction o f  acetaldehyde, the classical substrate o f  the 
enzyme, which indicates that pNSP is an excellent substrate for the liver enzyme. 
Moreover, the higher Km for acetaldehyde may indicate a greater affinity o f  the enzyme 
for the larger /?NSP substrate.
In a study that compared HLADH with class II tr-ADH, Maskos and Winston (37) 
observed a spectral intermediate in the reaction o f HL ADH-dependent reduction of 
pNSP that was not present in the reaction catalyzed by tt-ADH. This intermediate was 
identified base on its spectral characteristics as BQI. Assuming that the initial stages of 
the /jNSP reductase reaction are identical for both ADH isozymes, it was suggested that 
the human n-ADH removed BQI more efficiently than HLADH removed h. This led 
Maskos and Winston (37, 87) to propose a dual mechanism for the reduction of/jNSP 
by ADH. The first mechanism, attributed to jt-ADH, invisages a homogeneous 
chemical reaction that is coupled between two successive electron transfer reactions. 
During ADH-dependent reduction o f pNSP, coordination of the nitroso oxygen to the 
active she zinc activates the substrate for nucleophilic attack by NADH, which yields p-
hydroxyaminophenol and NAD+ at the active she. The p-hydroxyaminophenol may 
then undergo rapid dehydration to /vbenzoquinoneimine, which is subsequently reduced 
in an ADH-dependent manner to pAP. In the other mechanism, BQI is released from 
the ADH active she and undergoes a non-enzymatic reaction to form an arylnhrenium 
ion. This nitrenium ion may undergo subsequent hydrolysis to benzoquinone or 
nonenzymatic NADH-dependent reduction to pAP. This latter mechanism was 
suggested for HLADH. The present data indicates that all o f the human class I and
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class II ADH studied are capable o f  catalyzing the 2-electron reduction o f 1,4- 
benzoquinoneimine to pAP. Class II rc-ADH was particularly efficient (kct/XM = 30 
pM*1 min'1). Uniquely, the class IV a-ADH enzyme is not indicated to catalyze 
benzoquinoneimine reduction. The apparent inability o f o-ADH to reduce BQI 
suggested a mechanism for pNSP reduction analogous to that for HLADH. However, 
the fact that a spectral intermediate in the o-ADH-catalyzed reaction was not detected 
precludes this assumption. The fact that the rate ofpNSP disappearance (0.189 
pmol/min/mg) is similar to the rate ofpAP appearance (0.180 pmol/min/mg) indicates 
that any intermediate formed in the a-ADH catalyzed reaction is efficiently removed. 
As stated previously, the initial step ofpNSP reduction involves ADH-dependent 
formation ofp-hydroxy amino phenol, which is then dehydrated to BQI. One possible 
explanation for the absence o f an intermediate in the o-ADH profile is that this isozyme 
may stabilize the hydroxyaminophenol, preventing dehydration, and may efficiently 
catalyze the direct reduction of the hydroxyaminophenol to pAP. It is also possible that 
the o-ADH does indeed catalyze BQI reduction; however, at 32 pM the concentration 
o f  BQI is insufficient to overcome diffusion and initiate catalysis. It is well known that 
class IV o-ADH exhibits a substantially higher Km for ethanol oxidation as compared to 
the other human enzymes. However, because reduction o f  pNSP leads to formation o f 
BQI at the active she of o-ADH, the obstacle imposed by diffusion into the active site is 
eliminated, thereby allowing immediate BQI reduction.
The present data show significant differences in the metabolism ofpNSP by 
purified human ADH and HLADH isozymes and in the sensitivities o f these ADH to 
inhibition by pyrazole. These results may prove important in the understanding o f the
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mutagenic activation o f C-nitroso intermediates in the metabolism o f arylamines and 
nitroarenes. Detailed characterization of the steady state kinetic parameters o f the C- 
nitroso reductase activity o f  these enzymes is presented in Chapter 4
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CHAPTER 4 EFFECT OF pH ON ALCOHOL DEHYDROGENASE 
DEPENDENT REDUCTION OF P-NITROSOPKENOL: 
COMPARISON OF HORSE LIVER AND HUMAN ISOZYMES
4.1 Introdaction
The ADH-dependent oxidation o f alcohols and reduction of aldehydes is 
critically dependent on one or more proton transfer steps. These proton transfers would 
be expected to involve ionizing groups at the active center o f the enzyme. A proton 
relay system has been proposed for HLADH catalyzed alcohol oxidation in which a 
proton is transferred from the alcohol to form an alcoholate anion that is bound to the 
active site zinc atom (88). In the relay, the proton is transferred through a hydrogen- 
bonded network from the alcohol to Ser 48, to the 2 '-hydroxyl o f the nicotinamide 
ribose, and finally to the His 51 imidazole, which acts as the terminal general base 
catalyst that transfers the proton to solvent. Structural analysis o f  human piPi-ADH 
shows that this hydrogen bond network is also present in this isozyme, in which 
threonine substitutes for serine at position 48 (27).
Evidence for the mechanistic importance o f ionizing groups at the active center 
o f HLADH has been obtained by examination o f  the pH dependence o f  individual 
reaction steps in the catalytic mechanism (70). Such studies, however, have led to 
different conclusions concerning the effect o f pH on the hydride transfer process. 
Brooks et al. reported base catalysis by a dissociating group with apK» o f 6.5 for 
hydride transfer from ethanol to NAD* (89). McFarland et al. (90) concluded that 
ternary-complex inter-conversion cannot be subject to acid-base catalysis by a protonic 
acid with a pK« between 6 and 10. These authors found that the rate o f  hydride transfer 
from NADH to aromatic aldehydes is nearly independent o f  pH within the range o f  6 -  
10.
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The present investigation was undertaken in order to establish the pH* 
dependence o f the ADH-catalyzed reduction o f  pNSP, a model C-nitroso compound. 
Herein, we compare the C-nitrosoreductase activities o f HLADH, human class I a a - , 
P iP r, and P2P2-ADH, class III x-ADH, and class IV o-ADH with respect to pH.
4.2 Materials and Methods 
4.2.1 Chemicals and Enzymes
Pyrazole, NADH, NADPH, HLADH, benzaldehyde and potassium ferricyanide 
were obtained from Sigma (S t Louis, MO). pAP,/>NSP, and phenol were obtained 
from Aldrich Chemical Co. (Milwaukee, WI). All other chemicals were o f the highest 
grade commercially available.
4.2.2 Expression of Human ADH Isozymes
E.coli JM105 cells containing the cDNA of individual human ADH isozymes 
subcloned into the EcoRI site o f the procaryotic expression vector pKK223-3 
(Pharmacia Biotech) were a generous gift o f Dr. Tom Hurley (Department o f 
Biochemistry and Molecular biology, Indiana University School o f Medicine, 
Indianapolis, IN 46202). The cells were grown at 37°C to OD595 > 0.6 in 4 L o f 
modified TB media (12 g/liter peptone, 12 g/liter yeast extract, 4 ml/liter glycerol, 17 
mM KH2PO4 , 72 mM K2HPO4) containing 50 pg/ml o f ampicillin and 50 pl/L of 
antifoam A. Then Z11SO4 and isopropyl-ft-thiogalactopyranoside was added to a final 
concentration o f 7 pM and 0.2 mM, respectively, to induce the expression o f the alcohol 
dehydrogenase gene. The cultures were then placed in a 16°C shaking water bath and 
incubated for 24 hrs. The cells were centrifuged at 5,000 x g and lysed in isozyme 
specific buffer (aa : 10 mM Tris, 1 mM benzamidine, 10 pM ZnS04, 2 mM DTT, pH 8;
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0i0i and fcfh: 10 mM Tris, 10 pM ZnS0 4 , 1 mM EDTA, 1 mM benzamidine, 1 mM 
DTT, pH 8; a: 50 mM Tris, 1 mM benzamidine, 2 mM DTT, pH 8.8; x : 10 mM Tris, 
10 pM ZnS04, 1 mM EDTA, 1 mM benzamidine, 2 mM DTT, pH 7.5) using 
ultrasonication (output control to 4.5 with a pulse o f 1 second and a duty cycle o f  50%) 
(91). The lysate was centrifuged at 35,000 x g for 35 min.
4.2.3 Purification of Enzymes
Purification procedures were modified from previous reported methods (83, 86, 
92). All o f the recombinant enzymes were initially purified from the lysate-supematant 
by batch chromatography over DEAE-cellulose (DE52, Whatman International, LTD.) 
equilibrated in the appropriate lysis buffer at 4°C. Alcohol dehydrogenase does not 
stick to the resin and was eluted in the column flow-through and concentrated.
The activity pools o f  the ADH isozymes 0i0i and 0202 were then buffer 
exchanged into 7 mM HEPES, 10 pM ZnS04, 1 mM EDTA, 1 mM benzamidine, 1 mM 
DTT, pH 7.7. The enzyme was then applied to an S-Sepharose column (Sigma 
Biochemicals, 100 ml resin). The bound enzyme was washed and then eluted with a 0- 
100% gradient o f 200 mM NaCL The active fractions were pooled and dialyzed into 50 
mM Tris, 10 pM ZnS04, 1 mM DTT, pH 7.5. The dialyzed sample was applied to an 
Affi-Gel Blue (BioRad Laboratories, 30 ml resin) equilibrated with the dialysis buffer. 
The bound enzyme was washed and then removed by bump stripping the column with 
800 mM NaCl in equilibration buffer. The eluted sample was then dialyzed into 10 mM 
Tris, 10 pM ZnS04, 0.5 mM DTT, pH 7.5 and, when not used immediately, stored in 
50% glyceroL
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The recombinant human aa-ADH isozyme was purified using modifications o f 
the procedure for purification o f the human PP isoenzymes. Briefly following batch 
chromatography over DEAE in lysis buffer, the enzyme was dialyzed into 7 mM 
HEPES, 10 pM Z11SO 4 , 1 mM benzamidine, 2 mM DTT, pH 7.2. The enzyme was then 
applied to an S-Sepharose column. The bound enzyme was washed and then eluted 
with a 0-100% gradient o f 250 mM NaCl. The active fractions were pooled and 
dialyzed into 50 mM Tris, 10 pM ZnSC>4 , 0.5 mM DTT, pH 7.5. The dialyzed sample 
was applied to an Afifi-Gel Blue equilibrated with the dialysis buffer. The bound 
enzyme was washed and then removed by bump stripping the column with 800 mM 
NaCl in equilibration buffer. The eluted sample was then dialyzed into 10 mM ACES, 
0.5 mM DTT, pH 6.8.
The recombinant a  isozyme was purified using the following procedure. 
Following DEAE chromatography, the flow through was buffer exchanged into 7 mM 
Sodium Phosphate, 1 mM benzamidine, 1 mM DTT, pH 6.4 by dialysis. The enzyme 
was then applied to a 100 ml resin S-Sepharose column equilibrated with dialysis 
buffer. The bound enzyme was washed and then eluted with a linear gradient o f  sodium 
phosphate from 7 to 65 mM. The active fractions were pooled and then dialyzed into 
20 mM Sodium Phosphate, 0.5 mM DTT, pH 8.
As with the previous isozymes, the supernatant containing the human class III x~ 
ADH isozyme was first subjected to DEAE chromatography. The elutant was then 
dialyzed against 10 mM Tris, 10 pM Zinc Sulfate, 1 mM DTT, pH 8 and then applied to 
a 100 ml Q-Sepharose (Sigma Biochemicals) column equilibrated with dialysis buffer.
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Class in x-ADH was then eluted from the resin with a 0-100% 200 mM NaCl gradient. 
Active fractions were pooled and dialyzed into 10 mM Tris, 0.5 mM DTT, pH 7.5.
Enzyme was detected after each purification step by protein determination and 
activity assays o f  each fraction. Pooled fractions were concentrated using the Centricon 
(Amicon) system at individual purification steps as needed.
4.2.4 Western Blot Analysis
To determine the extent o f purification and confirm the presence o f purified 
ADH isozymes SDS-PAGE and Western blot analyses were performed. SDS-PAGE 
and Western blots were done by standard techniques described by Laemmli (93) and 
Towbin et al. (94), respectively. For western blots, the primary antibody used to probe 
the blots was rabbit-anti-HLADH. The secondary antibody was an anti-rabbit 
containing biotinylated conjugate. The blot was then treated with alkaline phosphatase 
conjugated ExtraAvidin (Sigma) followed by staining with nitroblue tetrazolium and 5- 
bromo-6-chloro-3-indoly 1-phosophate in 100 mM sodium bicarbonate (pH 9.8) 
containing 1 mM MgCfe. A representative gel and western blot are presented in figures
4.1 and 4.2, respectively. A purification chart has been provided in Table 4.1. Total 
protein concentrations were determined by the method o f Bradford (95) using the Bio- 
Rad protein kit. Where minor bands were present, the concentrations o f the purified 
ADH isozymes were confirmed by taking densitometric scans o f SDS-PAGE gels and 
comparing those densities to a standard curve compiled using densities o f known 
concentrations o f  HLADH.
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Table 4.1 Purification chart for human alcohol dehydrogenase.
Sample Total Protein Total Total Activity Specific % Yield FP
voL Protein Activity
(ml) (mg/ml) (me) (umob/min) tT i g. S. fi
Sigma
35K 50 2.33 116.5 11.30 96.97 100 1.00
DEAE (cone) 20 1.44 28.8 8.72 121.10 77 1.25
S-Seph 30 0.04 1.2 3.75 1872.99 33 19.32
Beta 11
35K 65 2.91 189.2 7.42 51.01 100 1.00
DEAE (cone) 30 1.43 42.9 6.05 84.55 81 1.66
S-Seph 40 0.24 9.6 2.60 217.04 35 4.25
Affi Blue 30 0.10 3.0 2.31 461.41 31 9.05
Beta I
35K 80 1.99 159.2 48.63 488.73 100 1.00
DEAE (cone) 35 1.66 58.1 39.73 478.65 82 0.98
S-Seph 45 0.16 7.2 11.57 1446.38 24 2.96
Affi Blue 30 0.09 2.8 12.35 2684.37 25 5.49
Alpha
35K 74 0.70 51.8 8.39 239.63 100 1.00
DEAE (cone) 28 1.43 40.0 6.17 86.32 74 0.36
S-Seph 35 0.36 12.6 3.58 198.65 43 0.83
Affi Blue 30 0.14 4.2 2.90 413.80 35 1.73
Chi
35K 86 2.56 220.2 24.03 187.75 100 1.00
DEAE (cone) 20 2.36 47.2 23.33 197.69 97 1.05
Q-Seph 30 0.30 9.0 13.01 867.04 54 4.62
Q-Seph and S-Seph denote the respective sepharose columns; FP, fold purification; 
cone, concentrated.
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Lanes 1 2 3 4 5
Fig. 4.1 SDS-PAGE for class I aa-ADH purification steps. Gel was loaded with 5-10 
pg protein /lane and stained with coomasie blue dye reagent. Lanes represent: 1, a a -  
ADH 35{(.-supernatant; 2, aa-ADH DEAE pool; 3, aa-A D H  S-sepharose pool; 4, a a -  
ADH Affi-Gel blue pool; 5, Standards.
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Fig. 4.2 Western blot o f purified human ADH. 3-5 pg protein was loaded per lane. 
Blot was probed with rabbit-anti-HLADH antibody.
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4.2.5 Enzyme ^ s a y s
Formation ofpAP from pNSP was determined essentially by the method of 
Horie et al. (44) with modifications (48). pNSP (0.12-lmM) was incubated for 15 
minutes in the presence o f 1 mM NADH and an appropriate concentration o f purified 
HLADH or purified human ADH in a 100 mM MES, 51 mM NEA, 51 mM DEA three 
component buffer in a final volume o f 200 pi. The reaction was initiated by addition o f 
cofactor and terminated by addition o f 30 pi o f 1 M Na2CC>3. pAP formation was 
detected spectrophotometrically by subsequent addition o f 30 ml o f 5% (w/v) aqueous 
phenol and 20 ml o f  0.2% (w/v) potassium ferricyanide. The color was allowed to 
develop for at least 15 min and the absorbance was read at 630 nm on a Biotek P750 
Microplate reader. The concentration o f pAP formed was calculated from a standard 
curve o f commercially available pAP. Additional reactions contained 4.75 mM 
acetaldehyde.
4.2.6 Kinetic Analysis
ADH activities were measured by the method o f Bonniehsen et al. (61), which is 
based on spectrophotometric measurement o f NADH formation from NAD+ in the 
presence o f ethanol. Activity was monitored at 340 nm in a Hatachi spectrophotometer 
using a molar extinction coefficient o f  6.22 mM'1 cm'1 for NADH. To determine the 
recovery o f enzyme during purification and the stability o f the purified alcohol 
dehydrogenases, the activity was measured with 2.5 mM NAD+ and 33 mM ethanol 
(100 mM for cr-ADH) as substrates in 0.1 M glycine, pH 10.0 (for a a ,  Pi Pi, and o) or 
in 0.1 M sodium phosphate, pH 8.5 (P2P2). Activity measurements for the class III x-
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ADH were performed using 2.5 mM NAD* and 5 mM cinnamyl alcohol in 0.1 M 
glycine, pH 10.0.
4.2.7 Data Processing
Data were fitted to the appropriate rate equations using the statistical software 
Enzymes Kinetics (version 1.2) described by Cleland (96). The variation o f  the kinetic 
parameters with pH was determined by examining the rates at each pH value, with 
NADH present at a saturating concentration and the concentration ofpNSP varied. The 
Voux/Km values obtained from a fit to Eq. 1 at low pNSP concentrations for each pH, 
where v is the observed velocity, Vmax is the maximum velocity, Km is the Michaelis 
constant, and S is the concentration ofpNSP, were plotted against pH in a log-log plot 
(97). These pH profile curves were fitted to Eq. 2 to obtain pK values (96), where y is 
Vbux/Km and C is the pH-independent maximum value o f that parameter. K*> is the 
dissociation for groups on the enzyme or substrate. Equation 2 was used to fit a single 
ionization on the pH profile. The competitive inhibition constants were determined by 
fitting the data at each pH to Eq. 3. The value I represents the concentration of inhibitor 
and K, is the inhibition constant.
Equation 1 v = VmaxS/^M + S)
Equation 2 log y = log [C/(l + Kb/[H*])]
Equation 3 v = VmaxS/[KM(l + I/Kj) + S]
4.3 Results
The C-nitrosoreductase activities o f  natural variants o f the human ADH enzyme 
and HLADH have been compared and contrasted. The individual human isozymes
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were expressed in E. coli and, following purification, were analyzed for their ability to 
catalyze NADH-dependent reduction o f  pNSP to pAP in the direct reaction and in the 
NAD+-dependent coupled reaction in which NADH is generated from metabolic 
conversion o f NAD+ by ADH-dependent oxidation o f  ethanol. The effects o f  varying 
the pH on these reactions were also studied.
4.3.1 Determination of Kinetic Constants for C-Nitrosoreduction and Dependence 
on pH
The C-nitrosoreductase activity o f  each ADH isozyme was determined by 
measuring the production o f pAP as a function o f  the concentration o f  pNSP and pH. 
The reactions were run for 15 min at which time the amount o f pAP formed was 
determined colorimetrically at 630 nm as described previously (48, 73). The basis o f 
this assay is the conversion o f pAP to benzoquinonimine (BQI) by potassium 
ferricyanide with subsequent color development by aqueous phenol (44). HLADH 
catalyzes the reduction o f  pNSP by a mechanism that is different from that o f human 
isozymes (Chapter 3) (37, 87). Reduction o f  pNSP involves the formation o f BQI, the 
dehydration product ofpN-OHAP, as a reaction intermediate. Unlike with the human 
isozymes, the conversion o f  this intermediate to pAP is not efficiently catalyzed by 
HLADH (37). pNSP reduction and pAP formation rates catalyzed by human ADH 
isozymes are essentially identical (Table 3.2). The colorimetric assay, which detects the 
ultimate reduced product ofpNSP reduction, pAP, and any remaining BQI, is a  reliable 
method for measuring pNSP reduction catalyzed by ADH. As noted in Chapter 3, 
ADH-catalyzed formation o f  pAP from 300 pM pNSP was linear for at least 20 min 
with each o f  the isozymes studied. In these studies, the concentration ofpN SP did not 
exceed 1 mM as higher concentrations resulted in spectral interference o f  the assay due
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to the strong absorbance o f /7NSP. The v vs. S plots shown in figure 4.3 show that each 
o f the ADH enzymes approximated Michealis-Menten kinetics. Accurate quantitative 
measurement o f  for these reactions at higher pH was problematic because o f 
spectral interferences at the higher concentrations o f pNSP alluded to above. However, 
reasonable approximations o f  Km and Vm., for ADH-catalyzed reduction o f  pNSP were 
possible from the substrate concentration range studied.
The human ADH variants exhibited distinct pH profiles. The concentration o f 
hydrogen ion ([FT]) was shown to be a noncompetitive mixed type activator/inhibitor o f 
the ADH catalyzed reduction o f  /?NSP. The double reciprocal plots in figure 4.4 for the 
various human ADH show the dependence o f  both Km and VMX on the pH o f the 
reaction. Varying the pH o f  the enzyme-catalyzed reaction results in double reciprocal 
plots that intersect either below o r above the x-axis for all o f  the ADH studied, except in 
the case o f the class I aa-AD H, which shows a pattern more reminiscent o f competitive 
interactions. In the pH range studied, the HLADH and class IV cr-ADH-catalyzed C- 
nitro so red uctase activity decreased with increasing pH, Le. decreasing [H*], throughout. 
For the remaining human ADH isozymes C-nitrosoreductase activity reached a 
maximum or plateaued at lower pH values indicating an inhibitory effect o f  [FT] (Fig.
4.3 and 4.4). pNSP reduction by HLADH and a-ADH were maximal at pH values o f  6 
or greater, while reductions catalyzed by a a -  and x*ADH were maximal at 6.8 and 6.4, 
respectively.
In the pH range studied, pH 6 - 8 ,  pNSP can exist in two tautomeric forms, the 
predominate quinone mo noxime and the nitroso form. Equilibrium between these two 
forms involves a mesomeric common ion. In aqueous solution at pH > 6, pNSP exists
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Fig. 4.3 Effect o f  pH on the reduction o f />-NitrosophenoI. Reactions were conducted 
in a 0.1 M MES, 0.051 M NEA, 0.051 M DEA three component buffer system, ImM 
NADH, 0 .1 2 -1  mM pNSP, 4.8 mM Acetaldehyde. Enzyme concentrations: HLADH 
0.25 pg/ml, aa-A D H  0.8 pg/ml, PiPi-ADH 54.5 pg/ml, P2 P2-ADH 22.5 jig/ml, Xr 
ADH 3.75 pg/ml, ct-ADH 1.228 pg/mL Individual data points are the means o f at 
least 4 determinations.
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Fig. 4.4 Effect o f pH on the reduction o f /?-Nitro so phenol: 1/v vs. 1/S. Reactions were 
conducted in a 0.1 M MES, 0.051 M NEA, 0.051 M DEA three component buffer 
system, ImM NADH, 0 .1 2 -1  mM pNSP, 4.8 mM Acetaldehyde. Enzyme 
concentrations: HLADH 0.25 pg/ml, aa-A D H  0.8 pg/ml, PiPi-ADH 54.5 pg/ml, 
P2P2-ADH 22.5 pg/ml, x*ADH 3.75 pg/ml, ct-ADH 1.228 pg/ml. Individual data 
points are the means o f at least 4 determinations.
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primarily in the ion form with a wavelength maximum at 400 nm (98, 99). Maskos and 
Winston have determined that the pK value for the ionization of free pNSP is 6.20 ± 
0.05 (100). While the ionization ofpN SP appears to lower the binding affinity o f  pNSP 
to the active site of horse liver ADH, it does not totally prevent it. Thus, a significant 
decrease in activity between pH 6 and 6.4 may be attributable to the ionization o f  free 
pNSP. However, as seen in figures 4.3 and 4.4, pAP  formation catalyzed by individual 
ADH isozymes is not significantly altered in this pH range.
The apparent Km and Vm** for HLADH- and human ADH-catalyzed /?NSP 
reduction are presented in Table 4.2. Kinetic constants were determined using the 
kinetics programs of Cleland (96) and from Hanes-Woolf plots (97). Each ADH 
isozyme catalyzed pNSP reduction with maximum activities at acidic pH. values 
for pNSP reduction decrease with increasing pH. As seen in our previous studies 
(chapter 3), HLADH catalyzed the reduction o f pNSP at a rate significantly greater than 
the most active human isozyme tested, Le., a-ADH (96 vs. 24 pmol/min/mg at pH 6, 
respectively). The relative orders o f  activity were HLADH > a > a > x > P2 > Pi- The 
ADH isozymes exhibited slight variations in Km as the pH was varied. Michaelis 
constants for the class IV cr-ADH remained fairly stable between pH 6 and 7.4, then 
increased as the pH of the reaction was increased to pH 8 (0.72 mM to 1.73 mM), 
indicating a decrease in the enzymes affinity for the nitroso substrate at alkaline pH. In 
contrast, Km values for HLADH, P2 P2 -, and x*ADH decreased with increasing pH. Km 
values for pNSP reduction by a a -  and P 1P 1-ADH showed minima between pH 6.4 -  
6.8, and maxima at pH 8. O f the ADH isozymes studied, class I aa-A D H  presented the 
highest Km value for /?NSP, with a maximum o f 9.2 mM at pH 8.
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Table 4.2 pH dependence o f  the apparent kinetic parameters for the reduction o f  p- 
nitrosophenol by ADH isozymes.___________________________________________
Class Isozyme 6 6.4
pH
6.8 7.4 8
I HLADH Km 1.40 1.12 0.75 0.64 0.84
V «x 95.5 49.3 29.3 22.0 14.8
aa-ADH Km 2.53 1.48 1.92 2.81 9.18
V*™ 23.8 15.7 22.1 16.3 20.1
P.PrADH Km 1.82 2.08 1.18 1.42 2.78
Vnax 0.27 0.24 0.17 0.13 0.14
P2P2-ADH Km 1.25 1.20 0.95 0.63 ND
Vn** 0.86 0.49 0.43 0.21 ND
m  x-a d h Km 2.00 1.32 0.81 0.63 0.56
V m»x 6.72 4.71 2.50 1.38 1.04
IV o-ADH Km 0.72 0.74 0.86 0.98 1.73
V™, 14.4 10.5 7.42 5.64 3.87
Units for kinetic constants: Km, mM; V ^ ,  pmol/min/mg. Reactions were conducted 
in a 0.1 M MES, 0.051 M NEA, 0.051 M DEA three component buffer system, 1 mM 
NADH, 0.12—1 mM pNSP. Enzyme concentrations: HLADH 0.25 pg/mL, a a —ADH 
0.8 pg/ml, PiPi-ADH 54.5 pg/ml, P2 P2 -ADH 22.5 pg/ml, x*ADH 3.75 pg/mL, a- 
ADH 1.228 pg/ml. ND, Not Determined.
4.3.2 Determination of Ionization Constants forpNSP Reduction Catalyzed by 
HLADH and Human ADH
Table 4.3 shows the ionization constants for the free enzymes and the enzyme- 
substrate complexes. The constants were determined from secondary plots (example in 
Fig. 4.6) of the slopes and intercepts o f  the double reciprocal plots (Fig. 4.4) versus the 
inverse o f the concentration o f  hydrogen ion or from plotting log V ^ / K m  v s . pH (Fig. 
4.5). For all o f  the ADH isozymes the efficiencies for pNSP reduction decreased with 
increasing pH. Therefore, ionization constants were determined using a statistics 
program which determined the constants according to equation 2. With both methods
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HLADH
Fig. 4.5 pH-dependence o f the catalytic efficiency (log V^ / Km) for HLADH and 
human ADH-dependent reduction o f /?NSP. The curve drawn through the experimental 
data points was obtained by fitting the data to equation 2.
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Fig. 4.6 Secondary Plot o f  the slopes determined from pH-dependent double reciprocal 
plots versus Reaction conditions: 120 — 1000 pM pNSP; 3.75 mM NAD+; and
0.1 M MES, 0.051 M NEA, 0.051 M DEA, pH 7.4. Enzyme concentration: 1.228 
pg/ml o-ADH.
the ionizations effecting the reduction o f pNSP by the enzymes were equivalent despite 
the method o f determination. Each ADH isozyme showed a pK*,E (pK o f the free 
enzyme) o f 7.3 -7.7. Only for the class I a a -  and piPr ADH were the ionization 
constants for the enzyme-substrate complex significantly different from those o f the 
free enzyme (8.8 vs. 7.2 for aa-ADH, respectively). Standard errors for each 
determination were ± 0.1 or less.
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Table 4.3 Comparison o f the pKj>E and p K t^  values determined from secondary plots 
and plots o f log Vm —/ K m  against pH.___________________________________________
Secondary Plots log Vu i /K m
Class Isozyme___________ pK bE________ p K ^ _____________ pK bE________C
I HLADH 7.8 7.5 7.6 4.4
aa-ADH 7.2 8.8 7.5 1.1
PiPi-ADH 7.8 8.4 7.8 1.2
P2P2-ADH 7.4 7.6 7.4 4.7
in X-ADH 7.6 7.0 7.8 2.8
IV a-ADH 7.3 7.8 7.2 1.2
The values o f pK*,E and pKbES represent the pK o f the free enzyme and enzyme- 
substrate complex, respectively.
4.3.3 Inhibition Kinetics
The effect o f acetaldehyde on the kinetic parameters for reduction of pNSP was 
examined as a function o f  pH. Because the C-nitroso moiety is isosteric and 
isoelectronic with the aldehyde functional group (40) it was anticipated that 
acetaldehyde would competitively inhibit pNSP reduction by the various ADH. 
Inhibition by acetaldehyde was indeed competitive with respect to pNSP for all o f  the 
ADH isozymes in the pH range studied. To illustrate this point, Fig. 4.7 shows a 
Hanes-Woolf plot (S vs. S/v) for ct-ADH catalyzed />NSP reduction at pH 7.4 in the 
absence and presence o f 4.75 mM acetaldehyde where parallel lines indicate changes in 
Km without concurrent changes in Vmax- Apparent KjS for acetaldehyde are presented in 
Table 4.4. Inhibition constants range from 3.7 -  51 mM for all o f  the ADH at all pH 
values studied. The class I aa-A D H  isozyme was only inhibited by 4.75 mM
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Fig. 4.7 Competitive inhibition o f o-ADH catalyzed C-nitrosoreduction by 4.75 mM 
acetaldehyde. Reaction conditions: 120 -  1000 pM pNSP; 3.75 mM NAD+; and 0.1 M 
MES, 0.051 M NEA, 0.051 M DEA, pH 7.4. Enzyme concentration: 1.228 pg/ml <r- 
ADH.
acetaldehyde in the pH range o f  6.8 — 7.4. At pH values o f  6, 6.4, and 8, aa-ADH- 
catalyzed pNSP reduction was either not inhibited or showed increases in activity.
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Table 4.4 Apparent K< values for the inhibition o f  ADH-catalyzed pNSP reduction by 
acetaldehyde._________________________________________________________________
Class Isozyme 6 6.4
pH
6.8 7.4 8
I HLADH 5.6 24.3 32.1 17.2 27.3
aa-A D H NI NI 50.1 3.7 NI
P 1P 1-ADH 51.3 27.9 31.7 20.4 40.0
P2 P2 -ADH 10.6 28.1 11.3 9.4 ND
h i  x-a d h 41.7 14.3 9.7 15.0 18.4
IV a-ADH 20.7 24.2 29.4 15.8 10.8
Units for kinetic constants: K,, mM. Reactions were conducted in a 0.1 M MES, 0.051 
M NEA, 0.051 M DEA three component buffer system, ImM NADH, 0 .1 2 -1  mM
pNSP, 4.8 mM Acetaldehyde. Enzyme concentrations: HLADH 0.25 pg/mL, a a -A D H  
0.8 pg/ml, PiPi-ADH 54.5 pg/ml, P2 P2-ADH 22.5 pg/ml, x-ADH 3.75 pg/ml, a-A D H 
1.228 pg/ml. NI, No Inhibition. ND, Not Determined.
4.4 Discussion
The effects o f  varying the hydrogen ion concentration [H*] on the activity o f  
enzymes have close similarities to the effects o f  activators and inhibitors (101). 
Treatment o f  the effects o f  the [LL] may be viewed in the same way as other effectors 
and can yield valuable information on the nature o f  the kinetic mechanism obeyed by 
the enzyme. In addition, the characteristic ionization constants o f  amino acid side-chain 
groups may help to identify specific groups as playing a role in the reaction. Here, we 
have considered the effects o f  the [H*] on ADH-dependent C-nitrosoreductase activity, 
both in terms o f  kinetic analysis with the [H*] as the variable and in terms o f  the use o f  
the effects o f  pH to identify specific ionizing groups.
Kinetic and structural comparisons have illustrated that homologous enzymes 
can differ markedly in substrate specificity. Increasing the size o f  the active site 
enhances the reactivity o f  alcohol dehydrogenase with large substrates such as
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benzaldehyde but decreases the reactivity o f  small substrates such as ethanol (86). 
Although ADH isozymes have broad specificity, variations in amino acid residues in 
the substrate-binding pocket produce different activities, which may be o f  physiological 
significance.
The ADH isozymes studied catalyze the reduction o f pNSP at significantly 
different rates and exhibit different affinities for the nitroso substrate. The relative 
orders o f  ADH dependent pNSP reduction were HLADH > a a -  > a - >  x~> P2 P2- > 
P 1P 1-ADH. Seemingly in opposition to its high rate o f  catalysis with the nitroso 
substrate, the class I aa-A D H  exhibits the lowest affinity for pNSP as inferred from its 
comparatively high Km at each pH studied. While Km values for pNSP showed 
marginal differences over the pH range studied, V ^x values for each ADH isozyme 
showed significant variations with pH. However, the pH dependent variation in 
enzyme-catalyzed pNSP reduction is essentially the same for all o f  the ADH isozymes 
studied. The data shows that as pH is increased there is a concurrent decrease in pAP 
formation, i.e. C-nitroso reduct ion. Therefore, there is a  significant dependence o f 
ADH-catalyzed C-nitroso reduction on the [H*]. As seen in Fig. 4.3, at comparatively 
low [FT], pH 6.8 -  8, C-nitrosoreduction by each ADH isozyme is directly proportional 
to the increase in pH. When the pH is more acidic, formation ofpN SP is not directly 
proportional to decreases in pH, indicating a  change in ionization o f  either the enzyme 
or the enzyme-substrate complex. Ionizations associated with free substrate are 
important in various enzyme catalyzed reactions, however, as stated above, the pK* o f 
pNSP is 6.2, and thus, is not a consideration here.
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In these studies, acetakiehyde was employed as an alternate substrate in the 
ADH-catalyzed reactions. In this role, acetakiehyde would be expected to compete with 
pNSP and inhibit the formation o f the productive ADH-N ADH-pNSP ternary complex. 
As expected, the competitive inhibitor acetakiehyde decreased the efficiency of the 
ADH isozymes in the reduction o f pNSP. Furthermore, plots o f  log Vaiax/Km VS- pH for 
acetaldehyde inhibited reactions indicate the same ionizations as the uninhibited 
reactions (Fig. 4.8).
1.2 
1
—  0.8
1 0.6 -
BE
©
“  0.4 
0.2 
0
5.
Fig. 4.8 pH-dependence o f  the catalytic efficiency (log V ^ /K m) for ct-ADH- 
dependent reduction ofpNSP. Comparison o f  Control and 4.75 mM acetaldehyde 
inhibited reactions. Reaction conditions: 120 — 1000 pM pNSP; 3.75 mM NAD*; and 
0.1 M MES, 0.051 M NEA, 0.051 M DEA, pH 7.4. Enzyme concentration: 1.228 
pg/ml cr-ADH.
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I f  substrate binding does not affect the ionization constants, the effect will be 
truly noncompetitive, with Vmu and the slope changed but Km unaffected (101). In the 
simplest mechanism for inhibition, the inhibitor can bind both to the free enzyme to 
give an enzyme-inhibitor complex and to the enzyme-substrate complex to give an 
enzyme-substrate-inhibitor complex. I f  the inhibitor exhibits stronger effects on the 
enzyme than the enzyme-substrate complex both Km and will decrease with 
increasing concentrations o f  the inhibitor (101). In fig. 4.4, Lineweaver-Burk plots for 
HLADH, and x-ADH catalyzed C-nitrosoreduction show just such a pattern, with pH- 
dependent lines intersecting below the x-axis. On the other hand, Lineweaver-Burk 
plots for the class I a a - ,  PiPi, P2 P2 -, and class IV o-ADH, show pH-dependent lines 
intersecting above the x-axis, inferring that with these enzymes the inhibitor binds more 
strongly to the enzyme-substrate complex. As the concentration o f  NADH used in these 
studies was saturating, it can be assumed that the enzymes were present as enzyme- 
NADH binary complexes and pH effects associated with the free enzymes were in fact 
in the binary complex. Therefore, kinetic constants presented in Table 4.2 reflect 
changes in C-nitroso reduction due to ionizations o f  the ADH-NADH complex or the 
ADH-NADH-pNSP tertiary complex.
Many ionizable groups may be involved in an enzyme-catalyzed reaction. 
Typically, any given reaction mechanism requires that ionizable residues be in a 
particular ionic form for activity (101). The first residue to become protonated or 
deprotonated as the pH is adjusted from that which is optimum is the one that is 
reflected in a pH-dependent change in enzyme activity measurements (101). The 
ionizations o f  other groups at pH values farther from the pH optimum are undetectable
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because they affect only the equilibrium between inactive forms o f  the enzyme. 
However, other groups present in the enzyme may influence the ionization o f  the 
reactive group (102).
Structural studies o f  HLADH with coenzyme and substrate or inhibitors (23, 88, 
103) have indicated that the substrate binding site is lined with hydrophobic residues 
including Phe 93. Other amino acids that line the alcohol-binding cleft and that may 
affect substrate binding include Ser 48, Leu 57, Phe 110, Leu 116, Leu 141, and He 318 
(23); o f  these residues, Ser 48 is the only one that is ionizable. The kinetic properties o f  
human ADH with substitutions at residue 47 in the coenzyme-binding site are quite 
different. The differences in K m  and Vm*x o f  ethanol oxidation between the P i (3 i - A D H  
and P2 P2 -ADH isozymes has been attributed to the presence o f  the weaker base, His, at 
position 47 o f  P2 P2  in place o f  Arg in P 1P 1; it is the only difference between P 1P 1-ADH 
and P2 P2-ADH (6). Examination o f  the structure o f  HLADH reveals that Arg 47 
interacts with one o f  the adenosine phosphate oxygens o f  NAD+ (23). Both the horse 
EE and human ptpi ADH have Arg at position 47 and bind coenzyme with high 
affinity. Class I a a -  and class IV a-AD H  have either Gly at position 47, while the class 
I P2 P2 - and class III x-ADH have His at this position (18, 104).
When studying the reduction ofp-nitroso-N , N-dimethylanline (NDMA) by 
yeast ADH, Trivic and Leskovac (42) reported a pH profile that reflected a pK o f  8.6 
for a catalytically active enzyme group in the enzyme-NADH complex. This was 
concluded because the concentration o f  NDM A was less than Km, rates o f  the reaction 
were proportional to V ^ /K m, and the pH-profile reflected the dissociation in the 
enzyme-NADH complex (42). Kvassman and Pettersson (105), have proposed that the
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pH dependence o f  NADH binding is attributable to electrostatic effects o f  the coenzyme 
pyrophosphate group on the ionization o f  zinc-bound water. In the present studies, only 
ionization constants for the enzyme-substrate complex in reactions catalyzed by class I 
a a -  and P2 P2 -ADH were found to be 8.4-8.8. The calculated pK values o f  the free 
enzyme found in our experiments do not approximate the value o f  8.6. However, if we 
assume that the enzyme is present as enzyme-NADH complexes, then the wide range o f  
pKbE values obtained for the ADH isozymes in our experiments might also reflect 
dissociation o f  the ADH-NADH complex. As stated previously, dissociation o f  NADH 
is dependent on the binding strength (basicity) o f  the amino acid at position 47. The 0.6 
log unit change in the constants reflect changes in the am ino acid, 7.8 for HLADH and 
P 1P1-ADH (Arg 47), 7.5 for P2 P2 -ADH and x-ADH (His 47), and 7.2 for aa-A D H  and 
a-ADH (Gly 47).
From the profiles o f  log V ^ /K m vs. pH (Fig. 4.5), a  catalytically active enzyme 
group with a pKb o f  7.4 — 7.8 was implicated in catalysis. However, using deuterium 
isotope effects, Maskos and Winston have reported an enzymatic residue with a pK o f  
6.5-6.7 in the HLADH-NADH complex that is involved in the binding of/?NSP (87). 
This later ionization constant is typical o f  an imidazole ligand; however, imidazoles 
may exhibit pK’s in the range o f  5-8 in proteins (102, 106).
The catalytic zinc atom is bound at the bottom o f  the substrate binding pocket by 
three protein ligands; two sulfur atoms from Cys 46 and C ys 174 and one nitrogen atom 
from His 67. A water molecule or hydroxyl ion, depending o n  the pH, completes a 
distorted tetrahedral coordination (70). The zinc-bound w ater molecule is involved in a 
system o f hydrogen bonds which include Ser 48 (Thr 48 in m ost human and in yeast
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isozymes) and His S1 which comprise an obligatory proton relay system for catalysis 
(13, 19, 70). Mutagenesis o f  any one o f the residues o f the proton relay system 
inactivates ADH (107). In the relay, the proton is transferred through a hydrogen 
bonded network from the alcohol to Ser 48, to the 2 '-hydroxyl o f  the nicotinamide 
ribose, and finally to His 51 imidazole, which acts as the terminal general base catalyst 
that transfers the proton to solvent (88). Dissociation o f  the nicotinamide moiety 
follows.
Sekhar and Plapp (108) have reported that the pH dependence for binding o f 
NAD* to HLADH may arise when deprotonation o f His 51 reduces electrostatic 
repulsion with the charged nicotinamide ring or promotes ionization of the zinc-bound 
water through the connecting hydrogen bond network. The pH dependence for NAD* 
shows a bell-shaped pH dependence, with pK values o f 6.3 -  6.9 and 9 -  9.7, and the 
maximal rate at pH 8 (108). The pK near 9 has been assigned to the zinc-bound water 
(109). Light et al. proposed that since both the HLADH and aa-A D H  isozymes show 
pK values near 7, and both enzymes have His 51, it is likely that the pK at 7 involved 
the histidine residue linked in the hydrogen bonded system to the zinc-iigand (110). 
Jacobs et al. have suggested that the absence o f  a pH effect during the reduction o f 
aromatic aldehydes as seen in previous studies is consistent with electrophilic catalysis 
o f hydride transfer and that such catalysis could result from protonation o f substrate by 
a protonic acid-base catalyst or o f complexation by zinc (111). The data o f  McFarland 
and Chu (90) support this conclusion in that catalysis by protonic acid (with a pK 
between 6 and 10) would show strong pH dependence. While the pKbES in Table 4.3 
are not typical o f  His 51 when compared with previous data and may be the result of
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other ionizing groups in the ADH active sites, the significant difference in values for the 
class III x-ADH as compared to the other isozymes does imply that these ionizations 
reflect changes in the proton relay system.
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CHAPTER 5 OXIDATION OF 2,2’-THIODIGLYCOL BY ALCOHOL
DEHYDROGENASE: COMPARISON OF HUMAN LIVER 
ISOENZYMES
5.1 Introduction
Sulfur mustard is a poisonous chemical warfare agent. It was used as recently 
by Iraq to attack its own Kurdish population in the Iranian-occupied village o f Halbja in 
1988 (49). Public concern arises from possible exposure and potential health hazards 
resulting from destruction o f  stockpiles o f  these chemical agents. Scientific data are 
being accumulated concerning potential adverse effects, including toxicology, 
carcinogenicity, mutagenicity, and teratogenicity.
Soon after introduction into body tissues, hydrolysis o f  mustard occurs to form 
2,2'-thiobis-ethanol (thiodiglycol) and semimustard, which are relatively nontoxic. 
Recent research has shown that sulfur mustard inhibits serine and threonine 
phosphatases and that this inhibition was more closely related to the concentration o f 
thiodiglycol (TDG) than the mustard itself (52). Subsequent observations have shown 
TDG to be a substrate for horse liver alcohol dehydrogenase (HLADH) and ADH in 
human skin cytosol (53).
Mammalian zinc-containing ADH constitute an enzyme family o f multiple 
isoforms. O f these, HLADH is the most widely studied. HLADH is a dimer composed 
o f two 40 kDa monomers, each containing 374 amino acids and two zinc ions, one 
having a structural function and the other a catalytic function. Humans produce more 
than 20 ADH isozymes composed o f as many as nine different subunits (4). The horse 
enzyme shares between 60% and 87% sequence homology with the human isozymes. 
The latter have been assigned to their respective classes based on their electrophoretic
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mobilities and inhibition by pyrazole and its 4-alkylated derivatives. The overall 
residue identity shows 60% homology between classes; many residues at the active site 
are substituted, especially in the substrate-binding cleft, which is large and hydrophobic 
in the traditional ethanol-active liver enzyme o f class I, but different in the enzymes o f 
the other classes. These ADH classes also differ in their tissue distribution. However, 
individual ADH isozymes are identical regardless o f their tissue localization.
The class I a - ,  P—, and y-ADHs, with allelic variants o f  P and y (5, 6), are 
effectively inhibited by 4-methylpyrazole. Primary and secondary alcohols are 
typically good substrates for class I ADHs. Patterns o f class I ADH also vary because 
of allelic polymorphism within and among different racial groups. Variants involving 
the p subunit have been designated pi (Caucasian), P2 (Oriental), and p3 (African) (6). 
Homo- and heterodimers o f a , p, and y subunits o f human class I ADH are present in 
liver, kidney, skin, gastrointestinal tract and to a lesser extent lung (112).
Class II and class HI ADH consist solely o f one isozyme, rt-ADH and x-ADH, 
respectively, and are relatively insensitive to pyrazole inhibition. Class II ADH acts on 
primary aliphatic alcohols and aromatic aldehydes (7). All human ADH catalyze the 
oxidation o f ethanol; however, the Km o f  class II ADH for ethanol oxidation is 
significantly higher than that o f class I forms. O f the vertebrate ADHs that have been 
identified only class III ADH has been conserved in all organisms (8). Class III ADH 
functions in vitro as a glutathione-dependent formaldehyde dehydrogenase, which 
suggests that this was the original function that drove the evolution o f  ADH (10) and 
identifies the ADH family as part o f  the cellular defense system. The n  and x subunits
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share about 60% sequence identity with respect to each other and the other isozymes; 
these have not been observed to form heterodimers.
Class IV consists o f  o-ADH. The class IV cr-ADH has unique enzymatic 
properties, with exceptionally high Km and k^, values for ethanol and alcohols and 
aldehydes o f  physiological interest. Found predominately in the stomach, the ct-ADH  is 
considered to have a significant role in retinol metabolism and first-pass ethanol 
metabolism (11-13).
There has been extensive research done to elucidate the catalytic properties, 
expression and localization o f  ADH in mammalian tissues (113-116). Recently,
Cheung, et al. (117) characterized the ADH content o f  human skin. Heightened 
awareness o f  the biological threats imposed by chemical warfare agents has prompted 
the study o f the metabolism o f  these compounds and their intermediates. Herein, we 
have compared and contrasted the catalytic activity o f  HLADH and purified a a ,  pi Pi, 
P2P2, YiYi, %, n, and a  human ADH isozymes to oxidize TDG.
5.2 Materials and Methods
5.2.1 Chemicals and Enzymes
Tris-maleate and p-nicotinamide adenine dinucleotide were obtained from 
Sigma Chemical Co. (St. Louis, MO). Thiodiglycol and pyrazole were from Aldrich 
Chemical Co. (Milwaukee, WI). Horse liver alcohol dehydrogenase was obtained from 
Boehringer-Mannheim (Indianapolis, IN). All other chemicals were o f the highest 
grade commercially available. Purified human liver ADH isozymes were generously 
provided for these studies by Dr. Thomas Hurley, Department o f  Biochemistry and 
Molecular Biology, Indiana University School o f Medicine.
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5.2.2 Enzyme Assays
Thiodiglycol oxidation by alcohol ADH was determined according to Brimfield
et al. (1998) with modifications. All solutions were prewarmed to 30°C. Aliquots o f a
5 mM NAD* solution in 20 mM tris-maleate buffer, pH 7.6 was placed in the wells o f a 
96-well microtiter plate. A solution o f  the appropriate enzyme concentration diluted in 
20 mM tris-maleate buffer, pH 7.6 was added to each well. The microtiter plates were 
baseline determined in a THERMOmax MAXline Molecular Dynamics Microplate 
Reader running SOFTmax™ software and equipped for constant temperature 
(preincubated for 2 min). At the end o f  the preincubation period, the appropriate 
concentration o f  substrate in 0.85% saline at 30°C was added. The reaction was 
followed by measuring the change in absorbance at 340 nm for 5 min with mixing 
before each reading. Under the described conditions the ADH-catalyzed reactions were 
linear for at least 15 min and first order with respect to enzyme concentration. In 
reactions containing pyrazole, the volume o f  the NAD* solution added was reduced by 
10 pL and 10 pi o f  the appropriate concentration of inhibitor in tris-maleate buffer was 
added before the 2 min incubation. The total reaction volume was 250 pi. Ethanol 
oxidation was measured by the method o f  Bonnichsen et al. (61), which is based on 
spectrophotometric measurement o f  NADH formation from NAD* in the presence of 
ethanol.
5.2.3 Data Analysis
Kinetic constants for TDG were determined by monitoring the production of
NADH at 340 nm (e = 6.32 mM-1 cm '1). Km and values for TDG were calculated 
using the statistical software Enzyme Kinetics (version 1.2) described by Cleland (96)
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and from a fit o f the kinetic data to the Lineweaver-Burk equation [1/v = Km/CV ^S) + 
1/Vmax], where S is the concentration of TDG. (min*1) was obtained by dividing 
Vmax by the concentration o f  active sites assuming a subunit MW o f 40,000. Km and 
Vmax were confirmed from Hanes-Woo If plots. Ki values for inhibition by pyrazole 
were calculated from Dixon plots (118)
5.3 Results
53 .1  Oxidation of TDG by Purified Human ADH Isozymes
The specific activities o f each of the purified ADH isozymes were determined at 
saturating concentrations o f  TDG. Of the ADH isozymes class IV o-ADH exhibited the 
highest specific activity, which was 1632 nmol/min/mg in the presence o f400 mM 
TDG (Table 5.1). The specific activities o f the class I ADH were, respectively 123, 79, 
347 and 647 nmol/min/mg for the a a ,  PiPi, P2P2 and yiYi isozymes. The class II n- 
ADH exhibited the lowest activity, 12 nmol/min/mg protein. The class III x-ADH did 
not exhibit activity with this substrate even when followed for 1 hour with saturating 
levels o f  substrate and elevated levels of enzyme. Only long-chain aliphatic alcohols 
have been found to be good substrates of class III x-ADH (83).
When compared with ethanol oxidation, the relative orders o f activity were 
essentially the same, with the class I yiyi-ADH being 4-5 fold greater than the aa-ADH 
and the PiPi-ADH having notably lower activity. The specific activity for P2P2-ADH 
was about half that o f the ytyi-ADH, whereas P2 P2-ADH oxidized ethanol at a rate twice 
that o f ytyi-ADH. HLADH, also a class I isozyme, had a slightly higher specific 
activity than that o f  the yiyi-ADH, 780 nmol/min/mg versus 647 nmol/min/mg, 
respectively. The specific activity o f class IV a-ADH was approximately three times
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greater with respect to TDG oxidation and seven times greater with respect to ethanol 
oxidation than that o f  class I yiyi-ADH.
5.3.2 Kinetic Constants for ADH-Catalyzed Oxidation of TDG
Based on the specific activity measurements o f Table 5.1, only the class I and 
class IV ADH were subjected to more detailed kinetic analysis. All enzymes tested 
exhibited classical Michaelis-Menten kinetics (Figure 5.1A-C). The class I isozymes, 
a a ,  P 1P1, yiyi, and HLADH, exhibited K m ’ s  for TDG from 1.3-8.7 mM (Table 5.2).
The highest Km value for TDG oxidation among the class I isozymes was for P2 P2-ADH 
(48 mM). In these studies, HLADH was shown to catalyze the oxidation o f TDG with a 
Km of 6.1 mM and a o f 780 nmol/min/mg compared to Brimfield’s (1998) values
Table 5.1 Specific activities o f  ADH-catalyzed oxidation of thiodiglycol and inhibition 
by pyrazole (ImM).
Class ADH isozyme Specific Activity
(nmol/min/mg)
% Pyrazole
Inhibition
Alcohol Oxidation
(pmol/min/mg)
I a a 123 83 0.58
P.P. 79 100 0.11
P2P2 347 56 5.64
Y.Y. 647 90 2.06
II n 12 0 0.11
III X No Activity ------ 2.70(*)
IV a 1632 73 15.40
Activities are means o f  triplicate measurements. Specific Activities o f TDG were
determined at: 45 mM TDG with 2.8 fig/ml a a ,  45 mM TDG with 6.83 pg/ml Pi Pi, 200 
mM TDG with 6.9 pg/ml P2P2, 33.4 mM TDG with 1.6 pg/ml yiyi, 33.4 mM TDG with
4.4 pg/m l«, and 400 mM TDG with 0.21 pg/ml a-ADH. (,)Alcohol oxidase activity 
measurements for x-ADH were performed using cinnamyl alcohol. All alcohol oxidase 
activity measurements were in 100 mM Glycine, pH 10; except P2P2, which was in 100 
mM Sodium Phosphate, pH 8.5.
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Fig. 5.1 A Oxidation o f 2,2-Thiobis-ethanol by a a -  and PiPi-ADH. The experiments 
were conducted as described under Materials and Methods under the following 
conditions: 4.2 mM — 45 mM TDG, 2.77pg/ml aa-A D H ; 8.3 pM -  45mM TDG, 6.83 
pg/ml PiPi-ADH. All reactions contained 5mM NAD+in 20 mM tris-maleate buffer, 
pH 7.6. (Insert) Michaelis-Menten plot o f  V vs. S data for the oxidation o f TDG by a a -  
and p i p i - ADH. Each data point represents the mean ± SD o f  at least three trials.
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Fig. 5.IB Oxidation o f  2,2'-Thiobis-ethanol by P2P2- and yiyi-ADH. The experiments 
were conducted as described under Materials and Methods under the following 
conditions: 16.7 mM — 200 mM TDG, 6.9 pg/ml P2P2-ADH; 4.2 mM -  45 mM TDG,
1.55 pg/ml yiyi-ADH. All reactions contained 5mM NAD+in 20 mM tris-maleate 
buffer, pH 7.6. (Insert) Michaelis-Menten plot o f V vs. S data for the oxidation o f TDG 
by P2 P2- and yiyi-ADH. Each data point represents the mean ± SD o f at least three 
trials.
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Fig. 5.1C Oxidation o f 2,2-Thiobis-ethanol by cr-ADH. The experiments were 
conducted as described under Materials and Methods under the following conditions:
75 mM -  600 mM TDG, 0.21 pg/ml crcr-ADH. All reactions contained 5mM NAD+in 
20 mM tris-maleate buffer, pH 7.6. (Insert) Michaelis-Menten plot o f V vs. S data for 
the oxidation o f  TDG by cr-ADH. Each data point represents the mean ± SD o f at least 
three trials.
100
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
o f 3.7 mM and 220 nmol/min/mg, respectively. The class IV a  isozyme, which has a 
Km of 41 mM for ethanol oxidation (4), has a Km for TDG that is two orders o f 
magnitude higher than that o f the class I ADHs at 255 mM. Michaelis-Menten plots for 
the a  isozyme showed a linear increase in activity up to approximately 200 mM 
approaching V,™* at 300-400 mM TDG (Figure 5.1C). Above 600 mM the reaction was 
noticeably inhibited, for example, in the range o f  800 mM -  1 M (data not shown) the 
oxidative activity o f  cr-ADH is reduced by half, probably due to ionic perturbations by 
these very high substrate concentrations. Exhibiting the highest activity o f the ADH 
isozymes tested, Vmax for cr-ADH was 2545 nmol/min/mg protein (kcat =1018 min'1). 
Class I a a -  and PiPi-ADH oxidize TDG with approximate Ic^/Km values o f 7-9 mM-1 
min'1 and yiyi had a value o f about 187 mM'1 m in 1. The Ic^/Km for cr-ADH was 
estimated at about 4 mM'1 m in1. Caution needs to be exercised when interpreting the 
kinetic data o f cr-ADH. We note that the reaction appears first order with respect to 
substrate concentration to above 200 mM. At such high concentrations ethanol displays 
substrate inhibition o f other ADH (119). Therefore, we cannot be certain whether the 
plateau in the v vs. S plot for cr-ADH is a true reflection o f  saturation kinetics or 
substrate perturbation o f the ADH activity. If  the latter is true, then calculation o f a Km 
and hence catalytic efficiency may not be accurate. An equally valid interpretation may 
be that cr-ADH is highly efficient and may not be saturable by TDG even at high mM 
concentrations. That this hypothesis has credence is suggested by the relative 
efficiencies (Icc/Km) observed with longer chain (4-8 C) aliphatic alcohols and cr-ADH, 
which are more than two orders o f magnitude greater than that obtained with ethanol
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Table 5.2 Kinetic parameters for the oxidation o f thiodiglycol and ethanol by ADH
isozymes._______________________________________________________________
TDG Ethanol
Class Isozyme Km kcat kca/KM Km Kat kca/KM
HLADH 6.1 312 51 0.32 438 1369
a a 8.7 (7.9 ± 1.2) 60 7 4.20 54 13
P.P. 3.9 (4.7 ± 0.4) 36 9 0.05 18 376
P2P2 48 (54 ±5.3) 915 19 1.2 696 580
YiY> 1.3 (1.4 ± 0.1) 244 187 1.10 140 130
<T 255 (293 ± 87) 1018 4 41 1000 24
Units for kinetic constants: Km, mM; ka„, min' ; ko/KM, mM' min' . Enzyme 
concentrations used were: 2.8, 6.8, 6.9, 1.6 and 0.2 pg/ml respectively, for a a - ,  P1P1-, 
P2P2-, YiYi-, and ct-ADH. Values in parentheses are Km values calculated from 
hyperbolic curve fits o f the data with the software Enzyme Kinetics (version 1.2) by 
Cleiand (96). Data for ethanol oxidation catalyzed by a a - ,  yiY i- - and cr-ADH were 
from Pares et al. (120), for P1P1 from Bosron et al. (121), for P2P2 from Kedishvili et al. 
(122). and for HLADH from Lee et al. (123).
(112). In this regard, TDG most closely resembles a 5C aliphatic alcohol in its 
structural motif.
5.3.3 Inhibition by Pyrazole of TDG Oxidation by Human ADH
Using the most active isozymes, we determined that 1 mM pyrazole, a potent 
inhibitor o f ADH, inhibited the class I a a - ,  P1P1-, P2P2- and YiY.' ADH, and class IV ct- 
ADH by 83, 100, 5 6 ,9 0 , and 73%, respectively (Table 5.1). Both pyrazole and 
acetaldehyde competitively inhibited the ADH catalyzed oxidation o f  TDG. Inhibition 
by these competitive inhibitors with respect to the aa-A D H  yielded apparent Kj values 
o f 82 and 161 pM, respectively (Table 5.3). Under the experimental conditions 
employed in these studies, the piPi isozyme was inhibited 100 % by 0.4 mM pyrazole 
and 2.3 mM acetaldehyde. The apparent Ki values for class I P2P2-ADH was 430 pM.
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The oxidation o f TDG catalyzed by yiyr ADH was also completely inhibited by 
pyrazole over the concentration range of 0.4 -  2 mM. By increasing the concentration 
of TDG to 40-75 mM, well above saturation o f the enzyme, activity measurements were 
obtained that allowed for the determination o f an apparent K{ for pyrazole inhibition 
from the slopes o f  double reciprocal plots o f uninhibited reactions and reactions 
containing 1 mM pyrazole. Pyrazole inhibition o f  class I yiyi-ADH catalyzed TDG 
oxidation showed an apparent K« o f  3.2 pM. Determination o f the apparent Kj’s for 
pyrazole and acetaldehyde inhibition of the ct-ADH catalyzed oxidation was hampered 
due to the variations in the ability to saturate the enzyme as discussed previously. In 
this experiment, the higher activity o f the ct isozyme may also lead to higher 
concentrations o f N A D H  being formed from the oxidation o f TDG. This higher 
concentration o f NADH  may drive the reduction o f  acetaldehyde, resulting in non-linear 
double reciprocal plots in these reactions.
Table 5.3 Apparent Kj constants for the inhibition o f  TDG oxidation by pyrazole and 
acetaldehyde._____________________________________________________________
Class Isozyme Pyrazole Acetaldehyde
I a a 82 161
P2P2 430 ND
YiYi 3.2 ND
IV CT 878 ND
Kj units are pM. ND denotes Not Determined. The experiments were conducted as 
described in Materials and Methods and K, values were calculated from Dixon plots. 
Enzyme concentrations used were: 2.8 pg/ml a a ,  6.9 pg/ml P2P2 , 1.6 pg/ml yiyi, and 
0.21 pg/ml ct-ADH.
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5.4 Discussion
Sulfur mustards are oily lipophilic liquids that penetrate skin and mucosal 
surfaces within 3 to 5 minutes after contact to provoke local discomfort both to the 
respiratory tract and to the skin (51). Employees in factories manufacturing mustard 
gas can become partially or totally disabled because o f injury to the mucosa o f the 
respiratory system after protracted exposure to small quantities o f mustard gas vapor. 
Typically, such workers develop an aggregate o f several symptoms, most notably 
problems of the eyes, respiratory tract, gastrointestinal tract, and the nervous system.
In previous incidents o f exposure to mustard in solution, the lungs, kidneys, and 
skin sustained the most damage. In general, 80% of mustard making contact with skin 
will evaporate, and the 20% remaining will penetrate the skin; however, only 2% o f the 
mustard becomes fixed, so that 18% is absorbed into the circulation to cause systemic 
intoxication (124). Nagy et al. (125) has estimated that as little as 6 pg/cm2 o f liquid 
sulfur mustard will cause lesions in human skin in most exposed sites. O f the three 
immediate target tissues o f chemical warfare agents, namely, the skin, eyes and 
respiratory system, the ones that are immediately susceptible to the toxic action o f 
mustard are the eyes (126). Mustard gas penetrates the cornea more rapidly than it does 
the skin, within 2 to 3 minutes after contact. The higher absorbance rate may lead to 
higher localized concentrations o f TDG in the eyes. Next to eye lesions, the greatest 
discomfort produced by exposure to mustard gas is that resulting from irritation and 
injury o f  the respiratory system (51).
Human gastric mucosa contains only the class I yiyi-ADH and the ubiquitous 
class III x*ADH (11). As discussed above, gastrointestinal problems have been
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identified in workers at factories that manufacture mustard gas from protracted 
exposure to small quantities o f mustard gas vapor. Therefore, if TDG oxidation is 
relevant to sulfur mustard toxicity as has been proposed by Brimfield et al. (1998), then 
the class I yiyi-ADH is indicated, based on our studies with purified enzymes, as a 
major catalyst in the sequelae o f toxic action. Again, the present data indicate that TDG 
is not a substrate o f class HI x-ADH.
Duester et al. (16,127) has reported that the ADH3 gene, which encodes class 1 
y-ADH, is inducible by certain chemicals. The ADH3 gene was found to possess a 
retinoic acid response element in its promoter region that may function in some tissues 
to regulate the amount of ADH activity in response to retinoic acid. It remains to be 
established whether or not yiyi-ADH is induced by TDG, but if this substrate behaves 
similarly to others for this isoenzyme it may account, at least in part, for the deleterious 
effects o f  TDG. We are not aware o f  any studies to indicate induction o f  class I yiyi- 
ADH by TDG; nevertheless, its marked catalytic efficiency toward TDG suggests that 
such a study would be of importance in regard to TDG exposure. To the best o f our 
knowledge class I yiyt-ADH is the only human ADH that has been shown to be 
inducible by xenobiotic agents.
Recent immunohistochemical studies have shown the presence o f  class I ADH 
and class III ADH enzymes in human skin, predominantly in the epidermis, with very 
little expression o f the class II protein in the epidermis and dermis (117). The severity 
o f skin lesions as a consequence o f exposure to mustard is dependent upon the dose of 
the agent, the humidity, and the length o f  exposure (128). It has also been shown that 
sweaty human skin incurred greater damage from mustard exposure because its
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sensitivity to the compounds was enhanced by a film o f  moisture on the skin surface 
(129). In this regard class I ADH was observed primarily in the microvasculature and 
sweat duct moisture (117).
The class I isozymes show significant differences in their abilities to catalyze the 
oxidation o f TDG. One difference is P2P2-ADH catalyzes a 5-fold greater rate of TDG 
oxidation compared to that o f  PiPi-ADH; the former is found in 65% o f Japanese and 
Chinese populations (130). These polymorphic variants are the result o f  a single amino 
acid substitution, Arg 47 for His in P2 (6), which is located in the coenzyme binding 
cleft and provides electrostatic stabilization for coenzyme binding (91, 92). Thus, the 
difference seen in the activity o f  these P variants may be attributed to the ability o f the 
Pi isozyme to bind NAD" in a more stable conformation, which may translate into 
slower release o f NADH as product (91). We are unaware o f  the existence o f data 
suggesting significant differences in the toxicity o f sulfur mustards amongst different 
ethnic groups. Nevertheless, the above indicates that such a study o f ADH-dependent 
oxidation of TDG in different ethnic groups is of heuristic value.
The class III x-ADH is expressed in most organ systems. Despite its presence in 
most tissues x-ADH does not catalyze TDG oxidation with up to 30 mM TDG thus, it is 
unlikely that x-ADH plays a role in TDG metabolism. X'ADH has a unique substrate 
binding site that encloses twice the volume of the p (pi substrate binding site (86). 
Cinnamyl alcohol, a preferred substrate o f x-ADH, has a large phenyl ring bound to a 
propenol moiety, which favors formation o f productive interactions within the active 
site. Also, the dihydric nature o f  the TDG molecule may favor unproductive 
associations with amino acid side chains lining the substrate binding site. Brimfield et
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al. (1998) found no evidence to suggest oxidation by ADH o f both hydroxyl groups o f 
TDG. One possibility is that through its associations with amino acid side chains the 
hydroxyl moiety that is not directly involved in oxidation may hinder the TDG from 
obtaining a productive orientation in the substrate binding she.
Class IV ct-ADH is the extrahepatic form of ADH found in the epithelial cells, 
especially the lining o f the stomach and esophagus (131). mRNA for a-ADH has also 
been detected in human cornea and skin. Assuming that localized TDG concentrations 
in the eyes following sulfur mustard exposure may be high due to the fast absorption 
rate, TDG may achieve its apparent high Km (122). However, even at TDG 
concentrations well below its Km, the class IV ct-ADH catalyzed oxidation o f TDG can 
exceed that of the other human ADH isozymes. Based on the v vs. [S] plot for TDG 
oxidation by ct-ADH (Fig. 5.1) we estimated the Km at greater than 200 mM, which 
translates to an enzyme with an efficiency (kcai/KM) for TDG oxidase of about 4 - 5  
mM'1 min'1. The substrate binding site o f ct-ADH is enlarged near the catalytic zinc ion 
and the middle region o f the substrate binding pocket is narrow. This enlarged active 
site would not restrict the binding modes o f  relatively small substrates, thus more non­
productive encounters between the enzyme and such small substrates will occur, which 
is reflected in higher Km values (86). In general, oxidation o f primary aliphatic alcohols 
by ct-ADH presents increasing catalytic efficiencies as the chain length increases, 
primarily a result o f decreasing Km values (4, 11). ct-ADH is unable to oxidize steroid 
alcohols and secondary alcohols efficiently. At pH 7.4, ct-ADH has a Km o f  120 mM 
for S(+)-2-ButanoI (4). At pH 10, a Km o f  140 mM is noted for cyclohexanol (11). 
Hurley and Vessell (132) have suggested that the enlarged entrance to the ct-ADH
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alcohol-binding site may yield fewer productive versus unproductive encounters 
between the enzyme and secondary alcohols.
The highest efficiency for TDG catalysis by the various purified human ADH 
studied was observed with the class I ytyi-ADH (>180 mM-1 min'1). ADH classes I, II 
and III are constitutively expressed in human skin, a major target o f sulfur mustard 
toxicity, with localization in specific regions o f the epidermis. We note that class I y-, 
a -  and the P-ADHs all catalyze TDG oxidation. ytyi-ADH was clearly the most 
efficient o f these; the value of kcu/KM was at least an order o f  magnitude greater than 
that o f the others (see Results) suggesting a marked potential for involvement in TDG 
oxidation by the skin. Although the class I isozymes can form heterodimers in vivo and 
the a , Pi, and p2 isozymes show significant TDG oxidase activity, implying that these 
isozymes may have a role in oxidizing TDG in vivo, their limited tissue distribution and 
the high catalytic efficiency o f the yt isozyme would seem to limit any significant 
participation o f  these isozymes in the action o f sulfur mustards in the primary target 
tissues. The class I a -  and p-ADH isozymes are not expressed in the eyes nor 
gastrointestinal tract. Class III x-ADH does not catalyze TDG oxidation; thus, it seems 
unlikely that this isoenzyme has a role in the oxidation o f TDG by human skin cytosol 
(53). Class II 7t-ADH catalyzed low level TDG oxidation (12 nmol/min/mg); however, 
because both liver and skin NADH-dependent cytosolic oxidation of TDG was potently 
inhibited by pyrazole and class II ADH is pyrazole-insensitive a minor role for this class 
o f ADH in TDG oxidation is suggested.
The low Kj value obtained for pyrazole inhibition with yiyi-ADH suggests a 
possible therapeutic role for pyrazole and 4-substituted pyrazoles in sulfur mustard
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toxicity if indeed ADH-dependent TDG metabolism is part o f  the toxic sequelae o f  
sulfur mustard. The high activity o f the ct-ADH, although less efficient than the y iy t- 
ADH, may account for sulfur mustard action in eyes, however, the apparent high Kj o f 
pyrazole inhibition may limit the effectiveness o f  pyrazole therapy. The exact role that 
the ADH-catalyzed oxidation o f  TDG plays in sulfur mustard toxicity has not been 
established. However, these studies may prove important in the interpretation o f  the 
interactions between sulfur mustard and metabolic systems o f humans.
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CHAPTER 6 SUMMARY
Liver cytosolic fractions are known to catalyze the reduction o f  certain C-nitroso 
compounds to their corresponding hydro xylamines and amines. C-nitroso compounds 
are highly reactive intermediates in the toxic sequelae o f  nitroarene metabolism.
Alcohol dehydrogenase, NAD(P)H: quinone oxidoreductase and xanthine and aldehyde 
oxidase have been implicated as C-nitroso reductases. To probe the role o f these 
cytosolic enzymes in the reduction o f C-nitroso compounds we have studied the effects 
o f classical inhibitors o f these enzymes on the ability o f  liver cytosolic fractions from
ADH+ and ADH" deermice to reduce />-nitrosophenol (pNSP) to />-amino phenol (pAP).
Pyrazole, a potent inhibitor o f  ADH, inhibited NADH- pNSP reduction by ADH+ 
cytosol by > 85%. Thus, ADH contributes substantially to NADH-C-nitroso reduction
by cytosol from ADH+ deermice. The NAD(P)H: quinone oxidoreductase inhibitor, 
dicumarol, inhibited NADH-dependent pAP formation about 25%; however, dicumarol 
potently inhibited the NADPH-dependent formation (90-95%). As expected, cytosol
from ADH" deermice did not catalyze pyrazole-sensitive (ADH-dependent) C-nitroso 
reduction with NADH as the cofactor. Both NADPH- and NADH- pNSP reduction by
ADH* cytosol was inhibited >90% by dicumarol. The xanthine oxidase/aldehyde 
oxidase inhibitor, allopurinol, was without effect on NAD(P)H cytosolic p-
nitrosophenol reduction from ADH" and ADH+ deermice under either aerobic or
anaerobic conditions. Our findings suggest that in the ADH+ animal, ADH contributes 
significantly to NADH-dependent C-nitroso reduction by cytosol relative to NAD(P)H:
quinone oxidoreductase. NADPH-dependent pNSP reduction by liver cytosol o f ADH4" 
animals is mostly dicumaro 1-sensitive which implicates NAD(P)H: quinone
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oxidoreductase as the major NADPH-dependent activity. In A D H ' deermice, both 
NADH- and NADPH-dependent /7-nitrosophenol reduction is essentially all dicumarol- 
sensitive (NAD(P)H: quinone oxidoreductase-dependent). Because the toxic expression 
o f  C-nitroso compounds are mediated by hydroxylamine intermediates, the present data 
indicate the importance o f  considering the role o f  ADH in the toxic sequelae o f  nitro 
and nitro so arenes.
ADH is a Zn-containing metalloenzyme. Although, extensive structural 
homology between horse and different isozymes o f  human liver ADH exist, significant 
differences occur within the active site, which account for great variability among 
substrate specificities, kinetic constants, and response to inhibitors. We have studied 
the metabolic activity o f  horse liver alcohol dehydrogenase (HLADH), purified class I 
oca, PiPi, and P2 P2 , class II n, class III % and class IV o  human isozymes, and human 
liver cytosol (HLC) towards the model C-nitroso substrate pNSP. Significant 
differences in the reaction rates o f  pNSP reduction and the sensitivity to pyrazole 
inhibition were observed between HLADH and the human isozymes. Class II n-ADH 
catalyzed pNSP reduction at a rate -1 0  times greater than did class I P2 P2-ADH and was 
relatively insensitive to pyrazole. The relative order o f  the rates o f  pNSP reduction by 
these ADH isozymes was HLADH > a a  > n >  a >  x > P2 P2 > ? !? !•  Interestingly, while 
pNSP reduction by HLADH proceeds via an observable spectral intermediate between 
252-257 nm, such a spectral intermediate is not apparent with the human isozymes. 
pNSP reduction catalyzed by HLADH, purified class I a a ,  P 1P 1, and P2 P2 , class III x 
and class IV a  human isozymes show pH dependence with maxima greater than or
i l l
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equal to pH 6. These pH dependence seemingly reflects a protein moiety involved in 
the proton relay system.
Sulfur mustard is a poisonous chemical agent that exerts local action on the 
eyes, skin, and respiratory tissues, with subsequent systemic action on  the nervous, 
cardiac, and digestive systems in humans. This toxic action is thought to be related to 
the generation o f 2,2’-thiodiglycol (TDG; also known as 2,2’-6w-thiodiethanol), the 
hydrolysis product o f sulfur mustard. TDG subsequently can undergo oxidation 
catalyzed by ADH. Human ADH isozymes differ in their tissue distribution.
Therefore, we have compared the catalytic activity o f purified human liver class I a , Pi, 
P2 and yi ADH, class II n ADH, class III x  ADH, and class IV a  ADH with respect to 
TDG oxidation. Specific activities with respect to TDG were 123, 79, 7, 647, and 8 
nmol/min/mg for the class I a , p,, p2 and yi ADH and class II it ADH, respectively. 
Class III x ADH did not exhibit activity with this substrate. The specific activity o f 
class IV cr ADH was estimated at about 2545 nmol/min/mg. 1 mM pyrazole, a potent 
inhibitor of class I and class II ADH, inhibited the class I a , Pi and yi ADH and class IV 
a  ADH by 83, 100, 90, and 73%, respectively. The class I a  and Pi ADH oxidized 
TDG with kci/KM values o f 8-9 raNf' min'1, and class I yi ADH with a  value o f 154 
mM"1 m in1. The Iccm/Km value for class IV a  ADH was estimated at 4  mM"1 min*1. The 
activities o f  class IV a  and class I yi ADH are of significant interest because o f their 
prevalence, respectively, in the eyes, lungs, stomach and skin, all potential target organs 
o f sulfur mustard toxicity.
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APPENDIX A THE PRESENCE OF URACIL-DNA GLYCOSYLASE IN 
INSECTS IS DEPENDENT UPON DEVELOPMENTAL 
COMPLEXITY2
A.l Abstract
The metamorphosis o f insects can, in a general way, be divided between those 
organisms that undergo pupation accompanied by cellular histolysis and those that 
gradually develop into adults without an intervening pupal stage o f development. In the 
former case, the death o f a cell population is an integral part o f development that is 
tightly associated with massive DNA degradation during pupation. In that regard, it has 
been suggested that uracil-containing DNA acts as a target for the nucleolytic 
breakdown o f DNA during histolysis in insects (133), thus placing into question how 
compatible the existence o f uracil-DNA glycosylases would be for this form of 
developmental signal. As a result, we tested for the presence o f a uracil-DNA 
glycosylase in insects representative o f those having an intervening pupal stage o f 
development and those that do not. We show here that a nonpupating insect contains a 
uracil-DNA glycosylase activity. Conversely, crude extracts of Drosophila 
melanogaster, as well as three other insect populations that undergo pupation similar to 
that found in Drosophila, do not contain detectable levels o f this DNA repair activity. 
Thus, there appears to be a consistent correlation between cellular destruction during 
development and the absence o f a uracil-DNA glycosylase, which supports the 
possibility that uracil-containing DNA may play an important role in those cells 
targeted for death.
2 Reprinted by permission o f the Journal o f Biological Chemistry.
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A.2 Introduction
Uracil is found in DNA either as the consequence o f mis incorporation during 
DNA synthesis or, alternatively, as the result o f  cytosine deamination. The latter event 
has been shown to be mutagenic, causing GC:AT transition mutations in bacterial 
strains lacking uracil-DNA glycosylase activity (ung ), thus demonstrating the 
importance o f this enzyme (134). Indeed, uracil-DNA glycosylases were assumed to 
exist in virtually all organisms. However, the ubiquitous nature o f this activity 
eventually came into some doubt when a number o f  laboratories failed to detect the 
repair o f uracil-containing DNA in extracts from Drosophila melanogaster (135-137). 
On the other hand, Drosophila was found to contain a nuclease that preferentially acts 
on uracil-containing DNA, but only in developmental stages prior to the cellular 
destruction observed during histolysis (136). In view o f this, a closer examination of 
uracil metabolism in Drosophila was undertaken. These studies revealed that the 
dUTPase activity responsible for keeping cellular dUTP levels low in relationship to 
TTP is also developmentally expressed and limited to embryonic stages coincident to 
the production o f  cells ultimately destroyed during pupation (138). Finally, an inhibitor 
of dUTPase activity was also detected in these early stages o f Drosophila development, 
where it was presumed that it acted to moderate dUTPase activity, thereby providing a 
greater opportunity for uracil incorporation into DNA (133, 139).
The novel features associated with uracil metabolism in Drosophila provided an 
experimental basis for suggesting that perhaps insects as a whole were deficient in 
uracil-DNA glycosylase activity (136). Recently, however, it was shown that 
Drosophila, as well as the locust Locusta migratoria, contains this DNA repair activity 
(140). Notably, the developmental pathways used by these two organisms are vastly
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different (see Table A. 1), giving us reasons to re inspect insects with regard to those that 
pupate like Drosophila as opposed to those insects like locusts that emerge from the egg 
and pass through immature stages o f  development (nymph) until they become sexually 
mature. In this paper, we confirm, using another nonpupating organism similar to the 
locust, the existence o f  a uracil-DNA glycosylase activity. On the other hand, we were 
unable to find this activity in Drosophila or in three other insect populations that 
undergo pupation. The absence o f uracil-DNA glycosylase activity may therefore be 
unique to only those insects that undergo pupation.
A.3 Materials and Methods 
A.3.1 Materials
Deoxy[5-3H]uridine 5'-triphosphate and deoxycytidine 5’-[a-32P]triphosphate 
were purchased from Amersham Corp. [a -32P] dUTP was prepared from [a-32P]dCTP 
by deamination o f  1 N NaOH as described by Johnson and Demple (141).
A.3.2 Preparation of [uracil-3H ,32P)Poly(dA-dT)
Poly(dA-dT) containing [urac//-3H ,a -32P]dUMP was made essentially as 
described by Johnson and Demple (141).
A .33 Assay of Uracil-DNA Glycosylase Activity
Reaction conditions were as described by Morgan and Chiebek (140), except for 
the manner in which assays were terminated and radioactive material was measured. 
Briefly, reactions (50pl) contained 40 mM Tris-HCl, 1 mM EDTA, 70 mM N a d , and 
radioactive poly(dA-dT). Incubations were generally for 20 min at 37°C, at which time 
assays were precipitated by the addition o f  20 pg o f calf thymus DNA, 110 pi o f 10% 
trichloroacetic acid, and 30 pi o f 5% Norit suspension and were centrifuged in a
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microcentrifuge for 15 min at 4°C (142). Radioactive material in the supernatant was 
determined by removing an aliquot and measuring for radioactive material.
Norit-nonabsorbed reaction products were determined by ascending 
polyethyleneimine-cellulose thin-layer chromatography as described by Gates and Linn
(143).
A.3.4 Insect Populations
Insects chosen for this study are identified in Table A. 1. Anticarsia gemmatalis 
eggs were from a colony kept in the Department o f Entomology, Louisiana State 
University, Agricultural Experiment Station, and were maintained according to 
previously described methods (144). Apis mellifera eggs were obtained from an active 
bee hive maintained by personnel o f  the Bee Breeding Laboratory, United States 
Department o f  Agriculture (Baton Rouge, La.). Diatraea saccharalis eggs were 
obtained from a laboratory colony maintained according to previously described 
procedures (145, 146). Acheta domesticus eggs and nymphs were collected from a 
colony maintained by the techniques described by Clifford et at. (147). D.
Melanogaster (Oregon-R) embryos were collected and stored as described by Deutsch 
and Spiering (136) and Giroir and Deutsch (138). Drosophila embryos that had not 
been subjected to dec ho rio nation were a generous gift o f  Dr. M. R. Kelley (Loyola 
Medical School, Maywood, 111.).
A.3.5 Preparation o f Extracts
Organisms identified in Table A. 1 were placed in 40 mM Tris-HCL, pH 8, 1 mM 
dhhiothrehol, 4 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 0.2 M NaCl and
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were homogenized in a glass homogenizer as described by Morgan and Chlebek (140). 
Cellular debris was generally removed by centrifugation at 12,000 x g.
A.3.6 Other Methods
Protein was measured by the technique of Bradford (95) using the Bio-Rad 
protein kit. Buffer pH values were routinely checked at 50 mM and room temperature. 
A.4 Results
The search for a uracil-DNA glycosylase activity in insects originally focused 
on an organism that closely parallels the type of developmental life cycle found in 
locusts (Table A. 1). The organism chosen was the cricket A. domesticus, which is a 
representative member o f a group o f insects that lack a pupal stage o f  development. 
Initial experiments did reveal some activity in this organism that was considerably 
enhanced when the pH optimum for the uracil-DNA glycosylase activity was 
subsequently discovered to be acidic and sharply centered around 6.0 (Fig. A. 1).
Table A .l Types o f insect populations tested for uracil-DNA glycosylase activity.
Endopterygota* Exopterygotab
A. gemmatalis (velvetbean caterpillar) A. domesticus (house cricket)
A. mellifera (honeybee)
D. saccharalis (sugarcane borer)
D. melanogaster
(a)These insects undergo larval and pupal stages of development and develop their wings 
internally until they are externalized at the pupal molt. (b>These insects lack a pupal 
stage and develop their wings externally. The locust L. migratoria, which was 
previously identified as having uracil-DNA glycosylase activity (140), is also a 
representative member o f  this group o f insects.
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Fig. A.1 Determination o f  pH optimum. Reactions (SO pi) contained 5 or 2 pg of 
Drosophila or cricket protein, respectively, and -100,000 cpm o f [«raci7-3H]poly(dA- 
dT). Assays were terminated with 144 pi o f Norit suspension and centrifuged, and the 
supernatant (50 pi) was determined for radioactivity.
A common characteristic shared by uracil-DNA glycosylases found in other 
organisms is their inhibition by free uracil (135, 148). The activity detected in crickets 
was also inhibited by uracil (Table A.2), suggesting that the liberation o f  Norit- 
nonabsorbed material was due to the presence o f an authentic uracil-DNA glycosylase 
protein. This was verified by separating the products o f the reaction by 
polyethyleneimine chromatography (Fig. A.2), in which 95% o f  the Norit-nonabsorbed 
radioactivity was detected coincident with authentic uracil. The remainder o f 
radioactive material migrated close to the origin o f the polyethyleneimine 
chromatogram and most likely was oligonucleotides produced by nonspecific nucleases.
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Table A.2 Uracil-DNA glycosylase activity in the bouse cricket (A. domesticus).
Organism Activity
pmol/min
A. domesticus 43
A. domesticus + 2.5 mM uracil <1
A. domesticus + D. melanogaster 42
D. melanogaster <1
Each reaction received 4 |ig o f  crude extract protein. In the mixing experiment, a 
protein extract (4 pg) o f  Drosophila was incubated for 5 min prior to the addition of a 
crude extract (4 pg) o f A. domesticus.
300
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Fig. A.2 Thin-layer chromatography o f reaction products. Complete reactions 
indicated that -3500 cpm o f 3H were liberated by extracts (2 pg) o f  1-day-old crickets. 
Thirty-two pi were applied to a polyethyleneimine-impregnated cellulose thin-layer 
plate along with authentic uracil and developed as described by Gates and Linn (143). 
Roughly 60% of the radioactivity applied to the chromatogram was recovered, with the 
majority as free uracil. # ,  plus extract; O, minus extract.
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The above experiments were conducted using 1-day-old crickets (nymphs), 
which appear to have more uracil-DNA glycosylase activity than do embryos (Table 
A.3). Furthermore, there is not a sharp and distinctive pH optimum for the DNA 
glycosylase activity observed in embryos (data not shown). Thus, it may be that 
different forms o f uracil-DNA glycosylase reside in crickets, one o f which is originally 
expressed at emergence from the embryo.
Table A.3 Uracil-DNA glycosylase activity in different insects.
Organism Activity
pmol/min
A. gemmatalis <1
A. mellifera <1
A. saccharalis <1
D. saccharalis first instar larvae <1
D. melanogaster <1
A. domesticus
Embryos, with chorion 15
Embryos, chorion removed 3
1-Day-old adult (nymph) 29
E. coli uracil-DNA glycosylase 84
E. coli uracil-DNA glycosylase
+ Drosophila extract 77
Reactions were conducted at pH 6.0, except for those using purified E. coli uracil-DNA 
glycosylase, which were assayed at pH 7.5. Incubations were for 20 min at 37°C. Each 
reaction received 5 pg o f  crude extract protein or 2 units o f E. coli uracil-DNA 
glycosylase capable o f  releasing 1 nmol o f free uracil in 1 h at 37°C. Unless otherwise 
stated, extracts were produced from organisms in the embryonic stage o f development.
Somewhat puzzling was the finding that there appears to be a relationship 
between the levels o f  uracil-DNA glycosylase activity detected and whether the insect 
was exposed to conditions to remove its chorion, as originally suggested by Morgan and
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Chlebek (140). As seen in Table A.3, roughly 5-fold more uracil-DNA glycosylase 
activity was observed in cricket embryos retaining intact chorions.
Having established the presence o f a uracil-DNA glycosylase in crickets, we 
then turned to evaluating Drosophila, which is an example o f an organism that 
undergoes pupation. We originally attempted to determine if, like crickets, the DNA 
glycosylase activity may also have an acidic pH optimum. However, tests performed at 
pH 5-8 foiled to reveal detectable amounts o f activity (Fig. A.1). Eliminating sonication 
proved to be an unsatisfactory means o f  revealing any activity, as did toluene treatment 
o f embryos or the use o f nondechorionated embryos (140). Thus, the use o f  a variety o f 
conditions failed to show detectable amounts or uracil-DNA glycosylase activity in 
Drosophila.
An obvious distinction can be made between Drosophila and crickets as to the 
manner in which they develop after embryogeneses toward the onset o f adulthood 
(Table A. 1). It therefore seemed reasonable to question whether insects that undergo 
pupation such as Drosophila also lack uracil-DNA glycosylase activity. As seen in 
Table A.3, three additional organisms that share the common feature o f undergoing 
pupation also lacked detectable amounts o f  activity on uracil-containing DNA. The 
extraction procedures or assay conditions were once again varied for experiments with 
the three other pupating species o f insects identified in Tables A.1 and A 3 , with the 
same unsuccessful results as for Drosophila.
One last question regarding the apparent absence of uracil-DNA glycosylase 
activity in Drosophila is whether there might be certain inhibitory factors present in 
their cells that could mask its detection. To test this, Drosophila extracts were
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combined with labeled uracil-containing DNA for 5 min, and then purified Escherichia 
coli uraci-DNA glycosylase was added and allowed to incubate for the normal 20 min. 
As seen in Table A.3, the presence o f Drosophia extracts had virtually no effect on the 
ability o f the E. coli enzyme to liberate uracil residues from DNA. Similar results were 
obtained when Drosophila extracts failed to inhibit the uracil-DNA glycosylase activity 
present in Bacillus subtilis (135). Likewise, combining extracts o f Drosophila and A. 
domesticus also failed to change the amount o f activity revealed by the cricket protein 
(Table A.2). Taken together, the inability to detect uracil-DNA glycosylase activity in 
Drosophila does not appear to be due to some endogenous protease or inhibitory factor. 
A.5 Discussion
After the formation o f the cellular blastoderm in Drosophila embryogenesis, 
segregation o f cells takes place; some o f  these cells are earmarked for their eventual 
destruction through a process known as histolysis. One o f  the characteristics associated 
with cellular death is DNA degradation, which could be mediated through a random 
nucleolytic attack on DNA or, perhaps instead, through a more selective pathway o f 
DNA degradation. For example, the inheritance of paternal versus maternal 
chloroplasts in Chlamydomonas is dictated by DNA modifications in which the 
maternal chloroplast is methlylated and stably inherited. Notably, paternal chloroplasts, 
which are degraded, contain the nonconventional base uracil in their DNA (149). Other 
examples exist in which the existence o f  modified or nonconventional bases in DNA is 
important for directing the breakdown or preserving the integrity o f DNA molecules 
(150, 151).
For the four insect populations examined in this study that undergo pupation 
(Table A. I), we found that they all share the same characteristic o f also lacking
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detectable levels o f  an enzyme necessary for the removal o f  uracil residues in DNA. 
One may explain these results by hypothesizing that these insects utilize uracil- 
containing DNA as a target for initiating the DNA degradation associated with 
pupation. This interpretation o f the data is reinforced by the previous finding o f  a 
protein inhibitor for Drosophila embryonic dUTPase (139), in which dUTPase is the 
main safety valve for preventing dUMP incorporation in DNA. Inhibition o f  dUTPase 
by a protein inhibitor has been identified in only one other organism, in which B. 
subtilis phage PBS2 induces an inhibitor o f  host-cell dUTPase, resulting in PBS2 
having the only known genome that contains uracil instead o f thymine in its DNA 
(152).
The presence o f a pathway that moderates dUTPase activity, thus providing a 
greater opportunity for uracil incorporation into DNA, suggests a strategy that in all 
likelihood is part o f a programed cycle that ultimately leads to the death o f certain cells. 
Programed cellular death is known to exist in Caenorhabditis elegans (153) and in the 
glucocorticoid-mediated cytolysis o f  thymocytes (154). In Drosophila, and perhaps in 
other insects that pupate, this program could involve the incorporation o f uracil into the 
DNA of cells targeted for destruction, most likely through the moderation o f  dUTPase 
activity (139). Subsequently, a nuclease expressed as part o f  the histolyzation process 
would selectively degrade the uracil-containing DNA (136). Clearly, the presence o f a 
uracil-DNA glycosylase would be incompatible with this form of instructed cellular 
death.
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HYPERBOLIC CURVE FIT 
FIT TO v = Vm*A/(K + A)
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